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Cysteine is one of the 22 natural amino acids used to make proteins.  Three pathways 
are currently known for the biosynthesis of cysteine and all include sulfide as the 
sulfur source.  A new pathway for cysteine biosynthesis was elucidated and 
reconstituted from Mycobacterium tuberculosis.  This pathway involves a protein 
bound thiocarboxylate (CysO-SH) as the sulfide donor, similar to thiamin and 
molybdopterin biosynthesis.  MoeZ, a paralog of ThiF (thiamin) and MoeB 
(molybdopterin), transfers sulfide onto CysO from an unidentified source.  Cysteine 
synthase M (CysM) catalyzes the addition of O-acetylserine to the carboxy terminus 
of the protein bound thiocarboxylate to generate a CysO-cysteine adduct.  A protease, 
Mec
+, hydrolyzes the CysO-cysteine adduct to release cysteine and regenerate CysO.  
Mec
+ contains the JAMM motif and this work provides the first functional 
characterization of the JAMM motif in prokaryotes.  This pathway could be important 
for M. tuberculosis under conditions of oxidative stress, as it would provide a more 
stable source of sulfide than the traditional pathways for cysteine formation.   
 
Vitamin B6, an essential cellular cofactor, is biosynthesized by bacteria and lower 
eukaryotes and is required in the human diet.  Two de novo pathways for PLP 
biosynthesis were known, however, the most common pathway involving the YaaD  
and YaaE family of genes had not been reconstituted.  The substrates for Bacillus 
subtilis PLP synthase (YaaD and YaaE) were identified as ribose-5-phosphate, 
glyceraldehyde-3-phosphate and glutamine; the product is pyridoxal-5’-phosphate.  In 
addition to PLP formation, we identified three activities catalyzed by the YaaD 
subunit of PLP synthase, including ribosephosphate isomerase activity, triose 
phosphate isomerase activity, and adduct formation with ribulose-5-phosphate.  We 
also investigated the early steps of the mechanism of pyridoxal-5’-phosphate 
formation.  In the absence of triose, PLP synthase forms a stable intermediate which 
absorbs at 320nm.  This intermediate then reacts with glyceraldehyde-3-phosphate to 
form PLP. 
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xiv Chapter 1 
 
 
Identifying a New Cysteine Biosynthetic Pathway 
 
1.1  Introduction  
As one of the twenty-two naturally occurring amino acids, cysteine plays an important 
role in many cellular functions.  Cysteine residues are often critical for enzyme catalysis 
and structure and serves as a source of sulfur for many cellular metabolites.  The pKa of 
the cysteine thiol is approximately pH8, which enables it to serve as a general acid or as a 
general base in enzyme catalysis, depending on the active site environment.  The thiol 
group is also very reactive as a nucleophile, broadening the scope of reactions that 
enzymes are able to catalyze.  Glyceraldehyde-3-phosphate dehydrogenase, an enzyme 
involved in glycolysis, is one of many enzymes that utilize cysteine as a nucleophile 
during catalysis.
1  Due to its nucleophilicity, cysteine is the site of many post-
translational modifications, and also serves as a target for site-directed labeling studies 
which allows researchers to study protein dynamics.  
 
In addition to its role in enzyme catalysis, cysteine also plays a structural role in many 
proteins.  Under oxidizing conditions, cysteine oxidizes to cystine, forming a disulfide 
bond between the two thiols.  Such disulfide bond formation at the protein level has 
several consequences.  Most disulfides form in secretory, lysosomal or membrane 
proteins, where the environment is non-reducing.  Both inter- and intramolecular 
disulfide bonds modify protein structure and stability, and can be essential for proper 
protein function.  Insulin is modified with disulfide bonds that are necessary for function 
and disulfide bonds in the protein keratin provide rigidity and strengthen our hair.   
 1   2
Disulfide formation in certain proteins in the cytosol is a sign of oxidative stress, and it 
triggers the cell to respond appropriately.
2   
 
Apart from its role in protein catalysis, structure and stability, cysteine provides a sulfur 
source for several cellular metabolites.  Cysteine serves as the sulfur donor, directly or 
indirectly, for the synthesis of all sulfur containing molecules in the cell.
3  It is the final 
step in the sulfur assimilation pathway and the first step in the biosynthesis of several 
essential compounds in the cell, including the cofactors thiamin, biotin, S-adenosyl 
methionione, molybdopterin and lipoic acid, the important cellular redox factor 
glutathione, as well as several siderophores and antibiotics.  Some of this structural 
diversity is shown in figure 1.1.   
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Figure 1.1  Structures of various sulfur containing metabolites. 
 
1.2  The biosynthesis of cysteine  
Cysteine is not an essential amino acid, and humans are able to synthesize their own by 
the reverse transsulfuration pathway.  This pathway uses methionine, an essential amino 
acid that is required in the diet, to make cysteine.  Only a few organisms have the reverse 
transsulfuration pathway, and most either use the direct sulfuration pathway or the 
   3
cystathionine pathway to synthesize cysteine.  All of these pathways first require sulfate 
assimilation to reduce sulfate to sulfide.   
 
Sulfate, the ultimate sulfur source of cysteine biosynthesis, is assimilated in bacteria, 
plants, and yeast by the route summarized in figure 1.2.  Sulfate is first transported into 
the cell by a sulfate permease.  Intracellular sulfate is adenylated by ATP sulfurylase, 
forming adenosine phosphosulfate 1.  This reaction consumes a lot of energy (Keq = 1.1 x 
10
-8; ∆G
o’
hydrolysis ~ -19 kcal/mol) and is highly disfavored, therefore it is coupled to the 
favorable hydrolysis of the β,  γ bond of GTP, which shifts the reaction equilibrium 
towards sulfate assimilation.
4  In bacteria, yeast, and fungi, adenosine phosphosulfate 
kinase phosphorylates adenosine phosphosulfate 1, resulting in 3’-phosphoadenosine 
phosphosulfate  2 (plants and algae do not have adenosine phosphosulfate kinase).   
Phosphoadenosine phosphosulfate 2 (or adenosine phosphosulfate in plants and algae) is 
subsequently reduced to sulfite 3 by the thioredoxin-dependent phosphoadenosine 
phosphosulfate reductase, yielding adenosine-3’-5’-diphosphate as the by-product.   
Sulfite 3 is reduced to sulfide 4 by NADPH-sulfite reductase, an enzyme that utilizes 
FAD as well as an iron-sulfur center and a siroheme prosthetic group.
5    
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Figure 1.2  Summary of the sulfate assimilation pathway found in bacteria, yeast, and 
fungi. 
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Although most organisms use the same pathway to assimilate sulfate, there are three 
known pathways to biosynthesize cysteine.  In most bacteria including E. coli, plants 
such as spinach,
6 and a few archaea,
7,8 cysteine is biosynthesized using the direct 
sulfuration pathway.  In this pathway, shown in figure 1.3, serine 5 is acetylated by serine 
acetyltransferase to form O-acetylserine 6.  Cysteine synthase K (CysK), which forms a 
complex with serine acetyltransferase, is a pyridoxal-5’-phosphate (PLP)-dependent 
enzyme that catalyzes the addition of sulfide 4 onto O-acetylserine 6 to form cysteine 7.  
Cysteine synthase M (CysM), an isozyme of CysK, does not complex with serine 
acetyltransferase and in vitro evidence suggests that it can use sulfide or thiosulfate to 
transfer sulfur onto O-acetylserine 6.  Evidence also suggests that CysM may be required 
for anaerobic growth because CysM mutants grow poorly under anaerobic conditions.
9,10 
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Figure 1.3  Reactions catalyzed by serine acetyltransferase and cysteine synthase in the 
direct sulfurylation pathway.   
 
In contrast to the direct sulfuration pathway, yeast and some bacteria use the 
cystathionine pathway to make cysteine (figure 1.4).
6  In the cystathionine pathway, 
homoserine  8 is acetylated by homoserine O-acetyltransferase.  O-acetylhomoserine 
sulfhydrylase transfers sulfide 4 to O-acetylhomoserine 9, forming homocysteine 10, 
which is also an intermediate in methionine biosynthesis.  Serine 5 and homocysteine 10 
are condensed by the PLP-dependent enzyme cystathionine β-synthase.  Cystathionine γ-
lyase cleaves cystathionine 11, releasing cysteine 7, ammonia and α-ketobutyrate 12.   
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Figure 1.4  The cystathionine pathway for cysteine biosynthesis, as found in yeast.   
 
The third pathway to cysteine is through reverse transsulfuration.  Reverse 
transsulfuration begins with methionine.  Methionine forms the cofactor S-
adenosylmethionine, which is demethylated to form S-adenosylhomocysteine.    This is 
cleaved to form homocysteine 10, which shuttles back into the cystathionine pathway 
shown in figure 1.4.   
 
1.3  Identification of a new cysteine biosynthetic gene cluster  
The biosynthesis of cysteine in Mycobacterium tuberculosis (TB) has not been studied 
extensively.  The sulfate assimilation pathway has just recently been characterized in 
TB
11 and genomic sequence analysis suggests TB could biosynthesize cysteine using 
several routes.  Recent analysis of a sulfate uptake mutant (cysA
-) that leads to 
methionine auxotropy and not cysteine auxotrophy in TB provides evidence for the 
reverse transsulfuration pathway in this organism;
12 however, the genome contains a 
cysteine synthase cysK gene (Rv2334) upstream of a putative serine acetyltrasferase, 
suggesting direct sulfuration may be responsible for cysteine biosynthesis (figure 1.3).  In 
addition to CysK, another putative cysteine synthase gene, cysM (Rv1336), exists in TB.  
This gene is clustered with two other genes in TB and several other organisms.  The 
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cluster, shown in figure 1.5, includes the genes mec
+ (Rv1334), cysO (Rv1335), and 
cysM, and is also present in Mycobacterium smegmatis, Nocardia farcinica, Streptomyces 
avermitilis, Streptomyces coelicolor, Streptomyces scabiei, and Thermomonospora fusca, 
all of which are gram-positive actinomycetes.   This gene organization suggests that they 
may work in a common pathway and since the gene cluster includes CysM, the 
organisms may employ a modified version of cysteine biosynthesis.  There are three lines 
of reasoning which suggest that this cluster may be responsible for a novel pathway for 
cysteine biosynthesis in these organisms, and these are listed below.   
 
1.3.1  Upregulation and coregulation of the cluster 
Bacterial cytoplasms are reducing environments and under conditions of oxidative stress 
such as the addition of heavy metals or reactive oxygen intermediates, cells have to 
respond appropriately to survive.  A result of oxidative stress is the formation of disulfide 
bonds in both proteins and small molecules and these disulfide bonds can become 
deleterious if they are not reduced.  One response to disulfide stress is the induction of a 
specific transcription factor, sigma (σ), which can bind to and upregulate a number of 
genes involved in the disulfide response as well as genes responsible for the biosyntheses 
of important sulfur-containing molecules.  Examples of genes upregulated under 
oxidative stress in bacteria include those for thioredoxin, sulfate uptake, and cysteine 
biosynthesis.  Both M. tuberculosis and S. coelicolor have a homologous sigma factor 
(σ
H and σ
R, respectively) that is induced upon oxidative stress.  Manganelli and co-
workers used microarray analysis to identify genes upregulated by σ
H in response to 
oxidative stress in M. tuberculosis.
13  In addition to thioredoxin and sulfate uptake genes, 
cysM, cysO, and mec
+ were all up-regulated in response to oxidative stress, and showed 
no upregulation in the σ
H mutant.  Likewise, Paget and coworkers mapped a consensus 
sequence for σ
R to a variety of genes in S. coelicolor
14.  Among the genes that have the 
consensus sequence were cysO and cysM, which they believe may compose one  
   7
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transcriptional unit.
14  No other genes involved in cysteine biosynthesis were shown to be 
upregulated in these experiments.  The results suggest that this cluster may be involved in 
synthesizing cysteine to overcome the potential deleterious effects of oxidative stress.  
 
1.3.2 Mec
+ is involved in cysteine biosynthesis 
In 1985, Hirasawa identified a gene, mec
+, which restored the nutritional requirement of 
methionine and cysteine in a mutant strain of Streoptomyces kasugaensis.
15  Although the 
S. kasugaensis genome has not been sequenced, related organisms’ genomes, such as S. 
coelicolor and M. tuberculosis, have been sequenced.   In these organisms, the mec
+ gene 
is clustered with cysM and cysO, as noted above.  This suggested that mec
+ plays a role in 
the cysteine biosynthesis in these organisms, although this activity has yet to be 
demonstrated.  This finding also suggests that for at least some of the actinomycetes, this 
cluster could be responsible for all of the cellular cysteine.   
 
1.3.3  Sulfide carrier protein 
Recently, the mechanism of sulfur transfer into the thiazole ring in thiamin biosynthesis 
in Bacillus subtilis was elucidated.
16,17  As figure 1.6 shows, a small protein, ThiS (7.6 
kDa) 13, is adenylated at the carboxy terminus to 14.  ThiS has two characteristic glycine 
residues at its carboxy terminus and the adenylation activates the C-terminal carbonyl for 
addition of sulfide, which is donated by cysteine via a cysteine desulfurase.  The sulfide 
on the thiocarboxylate 15 is eventually incorporated into the thiazole ring 16 of thiamin.  
Thus, ThiS acts as a sulfide carrier protein.   
 
A similar protein to ThiS has been found in molybdopterin biosynthesis.  E. coli’s MoaD 
(8.7 kDa) 17 also has two glycine residues at the carboxy terminus and has been shown to 
be activated by adenylation 18 for sulfide transfer, forming 19.
18  The sulfide at the 
carboxy terminus of MoaD is subsequently transferred into the cofactor molybdopterin 
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20, as shown in figure 1.6.  Proteins in the pyridine-2,6-dithiocarboxylate and 
quinolobactin (both sulfur containing siderophores) biosynthetic clusters have two 
glycine residues at the carboxy terminus and have been proposed to be sulfide carrier 
proteins for these secondary metabolites as well.
19,20  Interestingly, these clusters also 
contain a gene homologous to the mec
+ gene.   
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Figure 1.6   Sulfur transfer to the sulfur carrier protein ThiS in thiamin biosynthesis and 
MoaD in molybdopterin biosynthesis.   
 
Both ThiS and MoaD, the sulfide carrier proteins in thiamin and molybdopterin 
biosynthesis, share structural similarity to ubiquitin 21, the small protein that tags cellular 
proteins for degradation by the proteasome.
21,22  The activation of ubiquitin prior to 
tagging doomed proteins is similar to the activation of ThiS and MoaD for sulfide 
transfer.  Ubiquitin, which has two glycine residues at its carboxy terminus, is first 
activated through adenylation to 22.  The adenylation activates ubiquitin for conjugation 
to cysteine residues of E1 and E2 proteins.  E3 conjugates the doomed protein onto 
ubiquitin, which is then transferred to the proteasome.  At the proteasome, the Rpn11 
subunit releases ubiquitin and delivers the doomed protein into the proteasome for 
degradation (figure 1.7).    
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Figure 1.7  Ubiquitin is activated through adenylation followed by conjugation onto the 
E1 and E2 proteins.  E3 catalyzes the conjugation of doomed proteins onto ubiquitin, 
which is transferred to the proteasome.   
 
In the putative cysteine biosynthetic cluster in the actinomycetes mentioned above, the 
cysO gene (Rv1335) encodes a protein which shares 13% sequence similarity with B. 
subtilis ThiS.  This protein, which is 10 kDa, also has two glycine residues at the carboxy 
terminus.  Amino acid alignment of CysO and sulfide carrier proteins ThiS and MoaD as 
well as ubiquitin is shown in figure 1.8.  The similarity between these proteins suggests 
that CysO may be a sulfide carrier protein for cysteine biosynthesis.   
 
 
 
 
Figure 1.8  Amino acid alignment of sulfide carrier proteins ThiS, MoaD, ubiquitin and 
CysO using MultAlin.   
 
1.4  Biosynthetic proposal   
The  M. tuberculosis cluster, which is upregulated upon oxidative stress, encodes a 
putative cysteine synthase (CysM), a gene necessary for cysteine and methionine 
biosynthesis (mec
+), and a putative sulfide carrier protein (CysO).  We propose this 
cluster of genes is required to catalyze a novel route to cysteine, in which a sulfide carrier  
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protein is used instead of sulfide as the immediate sulfur donor.  Based on annotation and 
sequence homology, we propose the mechanism for cysteine biosynthesis shown in figure 
1.9.   
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Figure 1.9   Proposed mechanism of cysteine formation by the new cluster in M. 
tuberculosis.   
 
We propose the PLP-dependent deacetylation of O-acetylserine 6 by CysM, forming the 
α-aminoacrylate  26.  In the direct sulfuration pathway, sulfide would add to the α-
aminoacrylate 26 to form cysteine 7.   In our proposed pathway, the thiocarboxylate 27 at 
the carboxy terminus of CysO would add to the α-aminoacrylate 26, forming a covalent 
adduct between the small protein CysO and cysteine.  CysO would act as a sulfide carrier 
protein.  Following an S-N acyl shift, we propose that the mec
+ gene product, which is a 
putative protease, hydrolyzes the covalent adduct 28 to release cysteine 7 and regenerate 
CysO-carboxylate 29.  Mec
+ has a JAMM (Jab1/MPN domain metalloenzyme) motif, 
which consists of EXnHXHX10D and is found in a proteasomal subunit.  The two 
histidines and aspartate are proposed to chelate a metal ion, facilitating hydrolysis of the 
substrate.  The proteasomal subunit Rpn11 in budding yeast, for example, is proposed to 
hydrolyze the amide bond between the carboxy terminus of ubiquitin and the doomed 
protein sent to the proteasome (figure 1.7).
23  A similar reaction is proposed for Mec
+.    
 
As in thiamin and molybdopterin biosyntheses, we propose that CysO 29 would be 
activated through adenylation to 30 by a ThiF or MoeB-like protein.  There are no 
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proteins in or near the M. tuberculosis cluster that resemble ThiF or MoeB, however, the 
sequence of Pseudomonas aeruginosa PAO1 could provide some insights.  P. aeruginosa 
PAO1 contains the cluster of putative cysteine biosynthetic genes which was described 
above.  This cluster contains mec
+, cysM, an acetyltransferase gene, as well as a gene 
annotated as moeB.  The cluster is depicted in figure 1.10.  Interestingly, there is no cysO 
gene present in the cluster and there is no evidence of a cysO reading frame (no glycine-
glycine motif followed by a stop codon and no evidence of gene fusion with moeB).  The 
MoeB in P. aeruginosa PAO1 aligns well with a MoeZ protein (Rv3206) in M. 
tuberculosis (44% identity, 28% similarity) and this gene was upregulated by σ
H upon 
oxidative stress in M. tuberculosis, along with the putative cysteine biosynthetic genes.
13  
M. tuberculosis MoeZ contains a dinucleotide binding domain and a rhodanese domain, 
which could potentially serve as the adenylation and sulfide transfer protein needed for 
thiocarboxylate formation on CysO.  We propose that the gene product of Rv3206 
(MoeZ) will adenylate and transfer sulfide (from an unknown source) to CysO.   
   
mec
+ moeB cysM
acetyltransferase
 
Figure 1.10  Gene organization of a putative cysteine biosynthetic gene cluster in P. 
aeruginosa.  
  
In summary, we have described a unique set of genes that we believe is involved in a 
novel route to cysteine biosynthesis in several organisms.  We have outlined the proposed 
biosynthetic route and the first few chapters of this thesis will provide biochemical 
evidence for this new biosynthetic pathway for cysteine.   
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 Chapter 2 
 
 
Cloning, Expression and Gene Characterization
i
 
2.1  Reconstituting the pathway 
To determine whether the proposed biosynthetic pathway is correct, each gene had to be 
cloned, overexpressed and purified as a soluble protein.  The quickest way to determine 
whether this pathway was operable was to directly form the thiocarboxylate 27 on the 
carboxy terminus of CysO and check for adduct formation 28 with CysM and O-
acetylserine 6, as this was the most critical part of the proposal outlined in figure 1.9.  
Once the adduct formation was confirmed, we could test MoeZ for sulfide transfer to 
CysO.  This chapter describes the cloning, expression and activity assays for CysM, 
CysO and MoeZ. 
 
2.2.  Results and discussion 
 
2.2.1  CysM expression and activity assays 
M. tuberculosis cysM was cloned into a pET vector, overexpressed in E. coli BL21(DE3) 
cells and purified by Ni-Nta affinity chromatography.  The enzyme was stable in 50mM 
tris, pH8 and stored in 10% glycerol at -80
oC until use.  Typical yield for 1L of culture 
was 10 mg.  An SDS-PAGE gel of CysM is shown in figure 2.1a.    CysM purified with 
an absorption at 410 nm (figure 2.1b), indicative of a bound PLP cofactor.   
 
                                                 
i Reproduced in part with permission from Burns, K.; Baumgart, S.; Dorrestein, P.; Zhai, H.; McLafferty, 
F.; Begley, T. (2005) J. Am. Chem. Soc. 127, 11602-11603. 
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Figure 2.1   a.  12% SDS-PAGE of purified CysM protein.  Lane 1, MW markers; lane 2, 
pre-induction; lane 3, post-induction; lane 4, purified CysM  b.  UV-Visible absorption 
scan of pure CysM.  
 
CysM is annotated as a cysteine synthase, so we first tested sulfide 4 and O-acetylserine 6 
as substrates using the ninhydrin assay to monitor cysteine 7 formation.  Ninhydrin 30 
reacts with cysteine 7 under acidic conditions to produce a pink color (λmax 560nm) as 
shown in figure 2.2.
1  For M. tuberculosis CysM, cysteine 7 release is time dependent, 
enzyme concentration dependent, and substrate concentration dependent.  Kinetics were 
performed on CysM using this assay, and the Km for O-acetylserine is 4.4mM and the Km 
for sulfide is 40µM.   These compare well with data reported for other cysteine 
synthases.
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Figure 2.2  Ninhydrin assay for cysteine formation.   
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2.2.2  CysO-SH as a substrate for CysM 
To determine whether CysM catalyzes the formation of a cysteine adduct at the carboxy 
terminus of CysO, we used intein chemistry to generate the thiocarboxylate on CysO.
3  
Forming the thiocarboxylate in vitro by-passes the activation of CysO as well as the 
sulfide transfer steps so that we can rapidly test our hypothesis.  The IMPACT (Intein 
Mediated Purification with an Affinity Chitin-binding Tag) system was used to produce 
CysO-thiocarboxylate 27.  Briefly, cysO was cloned into the amino terminus of an intein 
construct that is engineered to self-cleave under specific conditions, and has a chitin 
binding domain (CBD) at the carboxy terminus for purification.  When added to chitin 
affinity resin, washed, and eluted with ammonium sulfide, the eluted protein contains a 
carboxy terminal thiocarboxylate, as depicted in figure 2.3.  CysO was eluted with 30mM 
ammonium sulfide and desalted into 50mM tris, pH8.  Purification of the CysO-
thiocarboxylate 27 is shown in the 15% SDS-PAGE gel in figure 2.4.   
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Figure 2.3   Summary of the intein processing used to produce CysO-thiocarboxylate 27. 
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Figure 2.4  15% SDS-PAGE of CysO-thiocarboxylate overexpression and purification.  
From the right:  lane 1, MW markers; lane 2, pre-induction; lane 3, post-induction; lane 
4, cleared lysate; lane 5, column flow through; lane 6, wash; lane 7, resin after 30hrs. of 
cleavage at room temperature; lane 8, resin after 30hrs. of cleavage at 4
oC; lane 9, elute 
from room temperature cleavage.   
 
Analysis of the CysO-thiocarboxylate 27 by ESI-FTMS (ElectroSpray Ionization Fourier 
Transform Mass Spectrometry) confirmed the formation of a thiocarboxylate with a peak 
at 9572Da.  CysO-thiocarboxylate 27 was incubated with CysM and O-acetylserine 6 in 
tris buffer at 37
oC for various times.  When analyzed by ESI-FTMS, a covalent adduct 
with mass of 9559Da appears with time, as shown in figure 2.5 (in collaboration with 
Huili Zhai and Fred McLafferty).  After 60 minutes, nearly all of the CysO-
thiocarboxylate 27 is converted to the 9559Da adduct, and without CysM in the reaction, 
no adduct forms after 30 minutes.  By MS/MS, the covalent adduct was localized to the 
carboxy terminus of CysO, as expected.  By MALDI (Matrix Assisted Laser 
Desorption/Ionization) mass spectrometry, when CysO-thiocarboxylate 27 and cysteine 
are incubated, no adduct is formed after one hour, suggesting that adduct formation is 
dependent on CysM.  TB’s other cysteine synthase, CysK (Rv2334), was cloned, 
expressed, purified and tested for adduct formation on CysO-thiocarboxylate 27.  CysK 
was unable to catalyze adduct formation on CysO, also suggesting the reaction was 
dependent on CysM (CysK was active as a cysteine synthase with sulfide 4 and O-
acetylserine 6 as substrates).  Likewise, when serine 5 was substituted for O-acetylserine   19
6, no adduct was formed, suggesting that the reaction is specific for O-acetylserine 6.  To 
determine whether the reaction is specific for CysO-thiocarboxylate 27, ThiS-
thiocarboxylate 15 (the sulfide carrier protein for thiamin biosynthesis shown in figure 
1.6) was added to the reaction mixture in place of CysO-thiocarboxylate 27 and no shift 
was observed by MALDI mass spectrometry.   
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Figure 2.5  ESI-FTMS analysis of the reaction between CysM and CysO-thiocarboxylate 
27 in the presence of O-acetylserine 6  a.  Reaction monitored by ESI-FTMS  b.  70µM 
CysO-SH, 33µM CysM, 13mM O-acetylserine, and DTT incubated for various times at 
37
oC.   
 
2.2.3  Expression and activity of MoeZ   
In the formation of ThiS-thiocarboxylate 13 in thiamin biosynthesis, ThiS is activated as 
an acyl adenylate 14 in a reaction catalyzed by ThiF (figure 1.6). The resulting ThiS-
adenylate then reacts with sulfide from cysteine desulfurase, which donates the sulfur for   20
ThiS-thiocarboxylate 15 formation.
4,5  Cysteine is the sulfide donor for ThiS, however, it 
is unlikely that it is the sulfide donor for CysO-thiocarboxylate 27 as well.  Although we 
have not yet identified the sulfide donor for CysO, we have identified a protein, MoeZ 
(Rv3206), which has a nucleotide binding domain and may activate CysO 29 through 
adenylation similar to how ThiF activates ThiS in thiamin biosynthesis.  BLAST searches 
reveal that MoeZ also has a rhodanese homology domain.  Proteins with this domain 
catalyze sulfide transfer, usually from thiosulfate or from mercaptopyruvate, to an 
acceptor molecule (in vitro the acceptor is 
–CN).
6,7  It is likely that MoeZ adenylates and 
transfers sulfide to CysO 29.   
 
To test whether MoeZ could catalyze adenylation and sulfide transfer to CysO, both 
MoeZ and CysO-carboxylate 29 were cloned, expressed and purified by Ni-Nta affinity 
chromatography.  When pure MoeZ was combined with pure CysO, we were unable to 
observe thiocarboxylate formation on CysO using ATP and sulfide 4 or thiosulfate as the 
sulfur source.   When MoeZ and CysO were co-lysed and co-purified from E. coli crude 
cell lysate, however, we were able to observe CysO-thiocarboxylate 27 formation as 
shown in figure 2.6 (in collaboration with Sabine Baumgart and Fred McLafferty).  We 
observe conversion to the CysO-thiocarboxylate 27 without the addition of exogenous 
substrates, which suggests that MoeZ is able to catalyze adenylation and sulfide transfer 
to CysO from an unidentified sulfur source that is present in E. coli.   
 
 
 
 
Figure 2.6  ESI-FTMS analysis of the MoeZ catalyzed sulfide transfer onto CysO. 
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2.3  Conclusion 
We’ve shown that a sulfide carrier protein from M. tuberculosis, CysO (Rv1335), in its 
thiocarboxylate 27 form, is modified to a cysteine adduct 28 by CysM (Rv1336) in the 
presence of O-acetylserine 6.  The reaction was specific for CysO, CysM and O-
acetylserine: no reaction was detected when CysO was replaced with ThiS 15, the sulfur 
carrier protein from thiamin biosynthesis; no reaction was detected when CysM was 
replaced by CysK, another cysteine synthase from TB; and no reaction was detected 
when O-acetylserine 6 was replaced with serine 5.  Preliminary results suggest that MoeZ 
(Rv3206) is responsible for activating CysO to the C-terminal thiocarboxylate 27, 
however, the details of this reaction, including the sulfur source, have yet to be 
established.  The results are summarized in figure 2.7. 
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Figure 2.7  In this pathway, MoeZ catalyzes sulfide transfer to CysO.  The CysO-
thiocarboxylate 27 combines with O-acetylserine 6 to form CysO-cysteine 28.   
 
2.4  Experimental procedures 
 
2.4.1  Materials and methods 
2.4.1.1  Materials:  pET16b vector was from Novagen, restriction enzymes from New 
England Biolabs, primers were ordered from Integrated DNA technologies.  M. 
tuberculosis H37Rv DNA was a gift from Clifton Barry, NIH.  Pfx Platinum polymerase 
was from Invitrogen.  A Perkin Elmer GeneAmp PCR System 2400 was used for PCR.  
QIAquick gel extraction kit and PCR purification kit were purchased from Qiagen, and   22
miniprep kit was from Promega.  T4 DNA ligase was purchased from New England 
Biolabs, One Shot TOP10 cells were from invitrogen.  Clones were sequenced at the 
Bioresource Center at Cornell University.  DH5α was used for propagation and storage; 
BL21(DE3) for overexpression; both were purchased from Novagen.  Ni-Nta resin was 
from Qiagen, chitin resin was from New England Biolabs and all chemicals were 
purchased from Sigma.  DG10 desalting columns were purchased from BioRad, and 
Centricon ultra concentrators were from Amicon.  Coommassie was purchased from 
Pierce.   
 
2.4.1.2  Cloning, Expression and Purification of CysM (CysM.16):  M. 
tuberculosis Rv1336 was amplified using the following primers:  5’for-GGG TGA GCG 
GAG CAT ATG ACA CGA TAC GAC-3’; 5’rev-TTC GGA TCC GGC GGA TCC TCA 
TGC CCA TAG-3’.   NdeI and BamHI restriction sites were added to the forward and 
reverse primer, respectively.  The gene was amplified using Pfx Platinum polymerase 
with a 1.5min extension time with M. tuberculosis H37Rv DNA as the template.  Upon 
purification of the PCR fragment from the agarose gel, the product and the pET16b 
vector were cut with NdeI and BamHI.  Enzymes were removed using the PCR 
purification kit and by agarose gel electrophoresis.  The cut pET16b vector and cut PCR 
product were ligated with T4 ligase at room temperature for 2 hours.  One Shot TOP10 
cells were transformed with 2.5µL of the ligation mixture and plated on LB-Amp plates.  
Colonies were checked for insert by prepping out the plasmid and cutting with 
Nde1/BamH1.  Colonies with insert were sequenced.   
 
E. coli BL21(DE3) cells were used for protein expression.  Cells were grown to an OD600 
of 0.5 and induced with 1mM IPTG at 25
oC.  After 8 hours of induction, the cells were 
harvested at 8,000 rpm for 10 minutes and stored at -20
oC until purification.   
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Cells containing overexpressed protein were resuspended in lysis buffer (20mM tris 
pH7.9, 500mM NaCl, 5mM imidazole) with lysozyme.  The cells were lysed by 
sonication (30-2 second pulses, 3 cycles), and the cell debris was removed by 
centrifugation for 30minutes at 17,000 rpm.  The cleared lysate was passed through pre-
equilibrated (with lysis buffer) Ni-Nta resin.  Following a quick wash with lysis buffer, 
the resin was washed with wash buffer (20mM tris pH7.9, 500mM NaCl, 60mM 
imidazole) until little protein eluted by Coommassie.  CysM was eluted with elution 
buffer (10mM tris pH7.9, 250mM NaCl, 500mM imidazole), desalted into 50mM tris 
pH8 using DG10 desalting columns, and concentrated.  CysM was stored in 10% glycerol 
at -80
oC until use.  Typical yield for 1L of culture was 10 mg. 
 
2.4.1.3  Cloning, Expression and Purification of CysO-thiocarboxylate 
(CysO.TYB1):  M. tuberculosis Rv1335 was amplified using the following primers:  5’ 
for-CCG AGA AAG GCC CAT ATG AAC GTC ACC GTA-3’; 5’ rev-CGT GTC ATG 
GCT CTT CCG CAC CCA CCG GCC ACG-3’.  NdeI and SapI restriction sites were 
added to the forward and reverse primer, respectively.  The gene was amplified using Pfx 
Platinum DNA polymerase with a 30sec extension time using M. tuberculosis H37Rv as 
the template DNA.  Upon purification of the PCR fragment from the agarose gel, the 
product and the pTYB1 vector were cut with NdeI and SapI.  Enzymes were removed 
using the PCR purification kit and by agarose gel electrophoresis.  The cut pTYB1 vector 
and cut PCR product were ligated with T4 ligase at room temperature for 2 hours.  One 
Shot TOP10 cells were transformed with 2.5µL of the ligation mixture and plated on LB-
Amp plates.  Colonies were checked for insert by prepping out the plasmid and cutting 
with PvuI (the SapI site is lost during cloning).  Colonies with insert were sequenced.   
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E. coli BL21(DE3) cells were used for protein expression.  Cells were grown to an OD600 
of 0.5 and induced with 1mM IPTG at 15
oC.  After 16 hours of induction, the cells were 
harvested at 8,000 rpm for 10 minutes and stored at -20
oC until purification.   
 
Cells containing overexpressed protein were resuspended in lysis buffer (20mM tris pH8, 
500mM NaCl, 1mM EDTA and 0.1% triton X-100).  The cells were lysed by sonication 
(30-2 second pulses, 3 cycles), and the cell debris was removed by centrifugation for 30 
minutes at 17,000 rpm.  The cleared lysate was passed through pre-equilibrated (column 
buffer:  20mM tris pH8, 500mM NaCl, 1mM EDTA) chitin resin.  The column was 
washed with column buffer until little protein eluted by Coommassie.  When little protein 
washed off, the column was quickly rinsed with cleavage buffer (20mM tris pH8, 
500mM NaCl, 1mM EDTA, 30mM (NH4)2S), capped and let sit at 4
oC for 40 hours.  
After 40 hours, the protein was eluted and immediately desalted into 50mM tris pH8 
using DG10 desalting columns, and concentrated.  CysO-SH was stored in 10% glycerol 
at -80
oC until use.  Typical yield for 1L of culture was 2 mg. 
 
2.4.1.4  Cloning, Expression and Purification of CysK (CysK.16):  M. 
tuberculosis Rv2334 was amplified using the following primers:  5’for-TGT TGG GCG 
TAG CAT ATG AGC ATC GCC GAG-3’; 5’rev-CAT GGC CGT CAG CTC GAG TTA 
GTC AGC CAC-3’.   NdeI and XhoI restriction sites were added to the forward and 
reverse primer, respectively.  The gene was amplified using Pfx Platinum DNA 
polymerase with a 1.5min extension time using M. tuberculosis H37Rv as the template 
DNA.  Cloning, expression and purification proceeded as for CysM.  CysK was stored in 
10% glycerol at -80
oC until use.  Typical yield for 1L of culture was 8 mg. 
 
2.4.1.5  Cloning, Expression and Purification of MoeZ (MoeZ.16):  M. 
tuberculosis Rv3206 was amplified using the following primers:  5’for-TAA CCG AGG   25
AGA CAT ATG GTG TCG ACA TCC-3’; 5’rev-GGG CCT GTA CTC GAG CTA GTA 
CAT CAC CAT-3’.   NdeI and XhoI restriction sites were added to the forward and 
reverse primer, respectively.  The gene was amplified using Pfx Platinum DNA 
polymerase with a 1.5min extension time using M. tuberculosis H37Rv as the template 
DNA.  Cloning, expression and purification proceeded as for CysM, except expression 
was only 4 hours.  MoeZ often precipitated upon purification if expressed longer than 4 
hours.  Typical yield for 1L of culture was 50 mg. 
 
2.4.1.6  Cloning, Expression and Purification of CysO (CysO.16):  M. 
tuberculosis Rv1335 was amplified using the following primers:  5’for-CCG AGA AAG 
GCC CAT ATG AAC GTC ACC GTA-3’; 5’rev-TCG TGT CAT GTC CTC GAG TCA 
CCC ACC GGC-3’.   NdeI and XhoI restriction sites were added to the forward and 
reverse primer, respectively.  The gene was amplified using Pfx Platinum DNA 
polymerase with a 30 second extension time using M. tuberculosis H37Rv as the template 
DNA.  Cloning, expression and purification proceeded as for CysM.  Typical yield for 1L 
of culture was 7 mg.   
 
2.4.2 Assays 
 
2.4.2.1  Materials:  All chemicals were purchased from Sigma.  Biospin-6 desalting 
columns are from Bio-Rad.  ESI-FTMS was performed by the McLafferty group at 
Cornell University.  MALDI data was collected at the Bioresource Center at Cornell 
University.    
 
2.4.2.2  Ninhydrin assay with CysM, O-acetylserine and sulfide:  In 1.2mL 
total, 39µg CysM was added to 10mM O-acetylserine, 10mM DTT in 100mM phosphate 
pH8 with various concentrations of Na2S (10µM – 200µM).  The reactions were kept at   26
37
oC.  At 1, 2, 4, 6 and 10 minutes, 200µL samples were withdrawn and added to 350µL 
of ninhydrin solution (1.3% ninhydrin in 1 HCl: 4 acetic acid).  After 10 minutes at 
100
oC, the samples were cooled, 700µL ethanol was added, and absorbance at 560nm 
was recorded.  Samples were done in triplicate and the blank had no enzyme.   
 
In 1.2mL total, 39µg CysM was added to 3mM Na2S, 10mM DTT in 100mM phosphate 
pH8 with various concentrations of O-acetylserine (0.4mM – 7.5mM).  Samples were 
analyzed as for sulfide.   
 
2.4.2.3  CysO-cysteine formation by ESI-FTMS:  13mM O-acetylserine, 300µg 
CysO-thiocarboxylate, and 6.7mM DTT were incubated with 480µg CysM in 50mM tris 
pH8.  After incubation at 37
oC for various time points, the samples were frozen at -80
oC.  
The samples were analyzed by ESI-FTMS. 
 
ThiS control:   ThiS-SH was formed in vitro using recombinant ThiSGF obtained from 
Pieter Dorrestein.  Briefly, 7.5mg ThiSGF was added to 126µg NifZ (provided by 
Colleen McGrath), 1mM cysteine, 4.3mM ATP and 4.3mM MgCl2.  After 2 hours at 
room temperature, 100µL of reaction was desalted into tris biospin-6 columns.  To 50µL 
of the desalted reaction, 26µg CysM and 6.7mM O-acetylserine were added in 67mM tris 
pH8 to a final volume of 150µL.  After 1 hour at room temperature (the sample at 37
oC 
precipitated, presumably due to ThiF, which is unstable), the samples were desalted into 
water and analyzed by MALDI mass spectrometry.   
 
CysO and cysteine control:  CysO-SH (unknown amount) was added to 1mM O-
acetylserine, 1mM DTT and 1mM cysteine in 100mM phosphate pH8 in 50µL total 
volume.  The sample was desalted into water after 1 hour at 37
oC and analyzed by 
MALDI mass spectrometry.     27
CysK control:  Purified CysK was active by the ninhydrin assay using O-acetylserine 
and Na2S as substrates.  10µg CysK was added to 75µg CysO-SH, 20mM O-acetylserine 
and 5mM DTT in 50mM tris pH8 in a total volume of 50µL for 1 hour at 37
oC.  The 
sample was desalted into water and analyzed by MALDI mass spectrometry.   
 
Serine control:  CysO-SH (unknown amount) was added to 100µg CysM, 1mM DTT 
and 1mM serine in 100mM phosphate pH8 in 50µL total volume.  The sample was 
desalted into water after 1 hour at 37
oC and analyzed by MALDI mass spectrometry.   
 
2.4.2.4  Copurification of CysO and MoeZ:  CysO and MoeZ were expressed 
separately in E. coli at reduced temperature.  After the cell pellets were resuspended in 
lysis buffer and incubated with lysozyme, the pellets were combined and sonicated, as 
usual.  Purification proceeded according to normal protocol.  The sample was desalted 
into 50mM tris pH8 and concentrated prior to analysis by ESI-FTMS.   
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 Chapter 3 
 
 
Studies on Mec
+i  
 
3.1  The JAMM motif 
The mec
+ gene (Rv1334), which encodes for a protein with a JAMM motif (Jab1/MPN 
domain metalloenzyme motif; EXnHS/THX10D), is clustered with the cysO and cysM 
genes in several actinomycetes (figure 1.5).  mec
+ was originally identified by its ability 
to restore the nutritional requirement for methionine and cysteine in a mutant strain of S. 
kasugaensis, however, no function was attributed to this gene at the time.
1  B L A S T  
searches annotate it as a metal-dependent hydrolase.   
 
The JAMM motif is found in archaea, bacteria and eukaryotes and until recently, no 
function was associated with it.  In 2002, Verma found that the eukaryotic JAMM motif 
found in the Rpn11 subunit of the proteasome is responsible for cleaving doomed 
proteins from the C-terminus of ubiquitin prior to delivery into the proteasome (figure 
1.7).
2  This process regenerates ubiquitin.  The amino acid sequence alignment of Rpn11 
and Mec
+ is shown in figure 3.1, with the JAMM motif highlighted with arrows.  Based 
on the JAMM motif homology, we propose that Mec
+ would cleave the cysteine from the 
C-terminus of CysO-cysteine adduct.  This process would generate CysO-carboxylate 
and cysteine, as shown in figure 3.2.  This chapter will describe the reconstitution of 
Mec
+ activity with regard to the proposed cysteine biosynthetic pathway, discuss the 
importance of the JAMM motif, and define the substrate specificity of Mec
+.    
                                                 
i Reproduced in part with permission from Burns, K.; Baumgart, S.; Dorrestein, P.; Zhai, H.; McLafferty, 
F.; Begley, T. (2005) J. Am. Chem. Soc. 127, 11602-11603. 
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Figure 3.1  Amino acid sequence alignment of Mec
+ and Rpn11 using MultAlin.  MT, M. 
tuberculosis Mec
+.  Arrows indicate the amino acids in the JAMM motif 
EXnHS/THX10D. 
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Figure 3.2  Proposed reaction catalyzed by Mec
+.  Figure 3.2  Proposed reaction catalyzed by Mec
+. 
   
3.2  Results and discussion  3.2  Results and discussion 
   
3.2.1  Expression and activity of Mec
+   3.2.1  Expression and activity of Mec
+  
M. tuberculosis mec
+ was cloned into the plasmid pET-MAL-HT (6 histidine residues at 
the carboxy terminus of maltose binding protein), which is a home-made vector made by 
Joanne Widom at Cornell University.  The maltose binding protein helped to solubilize 
Mec
+ (which was not very soluble as a his-tag construct) and the 6x histidine tag allowed 
for purification by Ni-Nta affinity chromatography.  The protein was cloned, 
overexpressed, purified and desalted into 50mM tris buffered to pH8.  An SDS-PAGE gel 
of pure Mec
+ is shown in figure 3.3.  Typical yield for 1L of culture was 7 mg.  
M. tuberculosis mec
+ was cloned into the plasmid pET-MAL-HT (6 histidine residues at 
the carboxy terminus of maltose binding protein), which is a home-made vector made by 
Joanne Widom at Cornell University.  The maltose binding protein helped to solubilize 
Mec
+ (which was not very soluble as a his-tag construct) and the 6x histidine tag allowed 
for purification by Ni-Nta affinity chromatography.  The protein was cloned, 
overexpressed, purified and desalted into 50mM tris buffered to pH8.  An SDS-PAGE gel 
of pure Mec
+ is shown in figure 3.3.  Typical yield for 1L of culture was 7 mg.  
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Figure 3.3  12% SDS-PAGE of purified Mec
+ protein.  Lane 1, MW markers; lane 2, pre-
induction; lane 3, soluble protein; lane 4, flow through; lane 5, wash; lane 6, eluted Mec
+.    
 
Upon addition of Mec
+ to reaction mixtures containing the CysM-derived cysteine adduct 
on CysO, we observe the formation of CysO-carboxylate 29 (9556Da) by ESI-FTMS 
(figure 3.4) (in collaboration with Sabine Baumgart and Fred McLafferty).  In addition to 
the hydrolysis of the adduct, we also observe the formation of cysteine 7 with ninhydrin, 
confirming that Mec
+ hydrolyzes cysteine from the carboxy terminus of CysO.  When 2.6 
nmoles of CysO-thiocarboxylate 27 was added to CysM and Mec
+ in the presence of O-
acetylserine 6, 2.7±0.16 nmoles of cysteine 7 were produced, indicating full conversion 
to cysteine.    
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Figure 3.4  ESI-FTMS analysis of the Mec
+ reaction  a.  Reaction containing CysO-SH 
27, CysM, O-acetylserine 6, and Mec
+  b.  Reaction containing CysO-SH 27 and O-
acetylserine 6.  
 
3.2.2  Mec
+ cleaves the amide bond 
Prior to cleavage by Mec
+, we propose the CysO-cysteine adduct 28  that is initially 
formed by CysM will undergo an S-N acyl shift to yield the more stable amide, as shown 
in figure 3.5.
3  To provide additional support for Mec
+ hydrolysis of the amide and not 
the thioester, we created a CysO construct containing an additional cysteine at the 
carboxy terminus and cloned it into a pET vector for overexpression (hisCysO-cysteine).  
Upon incubation of hisCysO-cysteine with Mec
+, we observe the production of cysteine 7 
by the ninhydrin assay and hydrolysis of the hisCysO-cysteine construct by ESI-FTMS.  
The mass spectrum is shown in figure 3.6a (in collaboration with Sabine Baumgart and 
Fred McLafferty).  To rule out the possibility that the hisCysO-cysteine construct was 
forming the thioester through an N-S acyl shift and that is what Mec
+ hydrolyzes, we 
created a CysO construct with an alanine residue at the C-terminus (CysO-ala).  This 
construct would be unable to form the thioester.  Mec
+ hydrolyzes the CysO-alanine   33
construct, which suggests that it recognizes and cleaves the amide and not the thioester at 
the C-terminus of CysO.   
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Scheme 3.5  Proposed non-enzymatic S-N acyl shift.   
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Figure 3.6  The reaction between the hisCysO-cysteine construct and Mec
+  a.  hisCysO-
cysteine with Mec
+  b.  hisCysO-cysteine, where Mec
+ was pre-incubated with EDTA  c.  
hisCysO-cysteine, Mec
+ pre-incubated with EDTA, and recovered with Zn
2+.   
 
3.2.3  Mec
+ is a metal dependent hydrolase 
Mec
+ is annotated as a metal-dependent hydrolase.  The protein is active upon 
purification, without addition of exogenous metal.  To confirm the dependence on a metal 
ion, Mec
+ was pre-incubated with EDTA and desalted to remove any chelated metal ion.  
No cysteine was evident by the ninhydrin assay when hisCysO-cysteine was used as the 
substrate for EDTA-treated Mec
+.  When Mec
+ was pre-incubated with EDTA, no 
hydrolysis is observed by ESI-FTMS as well (figure 3.6b).  Addition of Zn
2+ to this   34
reaction restored the hydrolytic activity (figure 3.6c), and Mg
2+ had no affect.  This result 
confirms that Mec
+ is a Zn
2+ dependent hydrolase, and it purifies with a bound metal ion.   
 
3.2.4  JAMM motif analysis 
To confirm the importance of the JAMM motif (EXnHS/THX10D) for Mec
+ activity, we 
used site-directed mutagenesis to mutate two of the conserved residues in the motif.   
Serine 89 and Aspartate 101 were mutated to alanine and the mutants were analyzed for 
cysteine production by the ninhydrin assay as well as hisCysO-cysteine hydrolysis by 
ESI-FTMS.  The ninhydrin assay indicated that no cysteine was produced and ESI-FTMS 
analysis of the hisCysO-cysteine construct also indicated that the mutants were inactive.  
This suggests that these two residues, and the JAMM motif in general, are essential for 
Mec
+ activity.     
 
3.2.5  Substrate specificity of Mec
+   
The proteasomal subunit Rpn11 is able to recognize and cleave the amide bond between 
ubiquitin and a lysine residue of the doomed protein.  Similarly, Mec
+ hydrolyzes the 
amide between CysO and a C-terminal cysteine residue.  Both ubiquitin and CysO are 
small proteins with two glycine residues at the C-terminus.  We wanted to understand the 
substrate specificity of Mec
+ to identify a possible recognition motif on CysO.  To 
determine the substrate specificity of Mec
+, a variety of CysO analogs were constructed 
and analyzed for hydrolysis by Mec
+.  The C-terminal cysteine residue was replaced by a 
serine (CysO-ser), an alanine (CysO-ala), an alanine-cysteine (CysO-ala-cys), and a 
cysteine-alanine (CysO-cys-ala).  These are displayed in figure 3.7.  All of these 
constructs were substrates for Mec
+, however, they were not as efficient as hisCysO-
cysteine.  In all cases, Mec
+ recognized and cleaved after the conserved C-terminal 
glycine residues on CysO, even in the CysO-ala-cys construct.  When one of the C-
terminal glycine residues was removed, cleavage by Mec
+ was greatly reduced,   35
indicating that the glycine residues at the C-terminus are important for recognition and 
cleavage and the residues following the glycines are not as important.     
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Figure 3.7  Structures of the CysO constructs made and tested as substrates for Mec
+.  
 
3.3  Conclusion 
The Mec
+ protein, a Zn
2+ dependent hydrolase, is able to recognize and cleave the amide 
bond at the C-terminus of CysO-cysteine 28.  This reaction releases cysteine 7 and 
regenerates CysO-carboxylate 29.  The JAMM motif requires a metal ion for activity, and 
this metal most likely activates water for hydrolysis of the amide bond.  The JAMM 
motif is important for catalysis; mutagenesis of two of the conserved residues abolishes 
activity, presumably due to the loss of the metal ion.  Although it appears that Mec
+ is 
promiscuous in its substrates, it has some specificity for cleaving after the C-terminal 
glycine residues of CysO.    
 
3.4  Experimental procedures 
 
3.4.1  Materials and methods 
 
3.4.1.1  Materials:  pET16b vector was from Novagen, restriction enzymes from New 
England Biolabs, primers were ordered from Integrated DNA technologies.  A Perkin 
Elmer GeneAmp PCR System 2400 was used for PCR and mutagenesis.  Pfx Platinum 
polymerase was from Invitrogen.  Site directed mutagenesis kit was from Stratagene.  
QIAquick gel extraction kit and PCR purification kit were purchased from Qiagen, and   36
miniprep kit was from Promega.  T4 DNA ligase was purchased from New England 
Biolabs and One Shot TOP10 cells were from Invitrogen.  Clones were sequenced at the 
Bioresource Center at Cornell University.  DH5α was used for propagation and storage; 
BL21(DE3) for overexpression; both were purchased from Novagen.  Ni-Nta resin was 
from Qiagen and all chemicals were purchased from Sigma.  DG10 desalting columns 
were purchased from BioRad, and Centricon ultra concentrators were from Amicon.   
 
3.4.1.2  Cloning, Expression and Purification of Mec
+ (Mec
+.MBPHT):  M. 
tuberculosis Rv1334 was amplified using the following primers:  5’for-TCG GGT CCT 
GAA GGA TCC GTG TTG CTT AGG-3’; 5’rev-GGC CTT TCT CGG CTC GAG TCA 
GTA CTG CTC-3’.   BamHI and XhoI restriction sites were added to the forward and 
reverse primer, respectively.  The gene was amplified using Pfx Platinum DNA 
polymerase with a 1.5min extension time using M. tuberculosis H37Rv as the template 
DNA.  Mec
+ was cloned into pMal.HT (6 histidine residues at the carboxy terminus of 
maltose binding protein), which is a homemade vector from Joanne Widom at Cornell 
University.  Cloning, expression and purification proceeded as for CysM.  Mec
+ was 
stored in 10% glycerol at -80
oC until use.  Typical yield for 1L of culture was 8 mg. 
 
3.4.1.3  Cloning, Expression and Purification of hisCysO-cysteine (hisCysO-
cys.16):  An additional cysteine residue was added to the carboxy terminus of CysO 
using the following primers:  5’for- CCG AGA AAG GCC CAT ATG AAC GTC ACC 
GTA-3’; 5’rev-CGG ATC CTC GAG TGA GCA CCC ACC GGC CAC GGC-3’.  NdeI 
and XhoI restriction sites were added to the forward and reverse primer, respectively.  
The gene was amplified using Pfx Platinum DNA polymerase with a 30 second extension 
time using CysO.16 as the template.  Cloning, expression and purification proceeded as 
for CysM.  hisCysO-cysteine was stored in 10% glycerol at -80
oC until use.  Typical 
yield for 1L of culture was 9 mg.   37
3.4.1.4  Cloning, Expression and Purification of CysO analogs:  CysO-cys.16 
was used as the template.  Cloning, expression and purification proceeded as for CysO-
cys.16.  CysO-cys-ala (CysO-CA.16):  5’for-CCG AGA AAG GCC CAT ATG AAC 
GTC ACC GTA-3’; 5’rev-CGG ATC CTC GAG TCA GGC GCA CCC ACC GGC 
CAC-3’ 
 
CysO-ser (CysO-S.16):  5’for-CCG AGA AAG GCC CAT ATG AAC GTC ACC GTA-
3’; 5’rev-CGG ATC CTC GAG TCA GGA CCC ACC GGC CAC GGC-3’ 
 
CysO-ala-cys (CysO-AC.16):  5’for-CCG AGA AAG GCC CAT ATG AAC GTC ACC 
GTA-3’; 5’rev-CGG ATC CTC GAG TCA GCA GGC CCC ACC GGC CAC-3’ 
 
CysO-ala (CysO-A.16):  5’for-CCG AGA AAG GCC CAT ATG AAC GTC ACC GTA-
3’; 5’rev-CGG ATC CTC GAG TCA GGC CCC ACC GGC CAC GGC-3’ 
 
CysO(G->A)+cys:  (CysOG->A-cys.16):  5’for-CCG AGA AAG GCC CAT ATG AAC 
GTC ACC GTA-3’; 5’rev-CGG ATC CTC GAG TCA GCA GGC ACC GGC CAC 
GGC-3’ 
 
3.4.1.5  Mutagenesis of Mec
+ JAMM motif residues:  Serine 89 was mutated to 
alanine from Mec
+.MBPHT using the following primers:  5’for-CGT CAT CTA TCA 
CGC GCA CAC TGC GAC CGA AGC-3’; 5’rev-GCT TCG GTC GCA GTG TGC GCG 
TGA TAG ATG ACG-3’.  Aspartic acid 101 was mutated to alanine using the following 
primers:  5’for-GCG TAC GCG AGC CGT ACG GCC GTG AAG CTT GCC-3’; 5’rev-
GGC AAG CTT CAC GGC CGT ACG GCT CGC GTA CGC-3’.  Stratagene site 
directed mutagenesis kit was used to amplify the plasmid DNA.  Expression and 
purification proceeded as for WT Mec
+.MBPHT.   38
3.4.2  Assays 
 
3.4.2.1  Materials:  All chemicals were purchased from Sigma.  ESI-FTMS was 
performed by the McLafferty group at Cornell University.  MALDI data was collected at 
the Bioresource Center at Cornell University.   
 
3.4.2.2  Ninhydrin assay for cysteine:  Briefly, 6mM O-acetylserine, 10mM DTT, 
250µg CysO-thiocarboxylate, 100µg CysM, 0.1mM Zn
2+, and 140µg Mec
+ were 
incubated in 100mM Phosphate buffer, pH 8.0.  Samples were withdrawn at appropriate 
times, ninhydrin was added, boiled for 10 minutes, cooled, and ethanol added.   
Absorbance at 560nm was measured.   
 
3.4.2.3  Cleavage of hisCysO-cysteine by Mec
+:   
255µg of hisCysO-cysteine, 10mM DTT, 10µM ZnCl2, and 45µg Mec
+ were incubated in 
50mM Tris, pH 8 for 1 hour, then frozen.  Samples were analyzed by ESI-FTMS. 
 
3.4.2.4  Metal-dependence of Mec
+:   
Ninhydrin:  100µg Mec
+ was pre-incubated with and without 0.1mM EDTA for 10 
minutes at room temperature.  The sample was desalted into tris bio-spin columns.  To 
the samples, 367.5µg hisCysO-cysteine and 8.5mM DTT were added to a final volume of 
350µL in 100mM potassium phosphate pH8.  To test whether activity could be restored 
with a metal ion, 0.1mM Zn
2+ or 0.1mM Mg
2+ were added to two of the samples.  At 15 
and 40minutes, 150µL was removed and 262µL of the ninhydrin solution was added.  
The samples were placed at 100
oC for 10 minutes, allowed to cool, and 525µL ethanol 
was added.  The absorbance at 560nm was taken for each sample.   
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ESI-FTMS:  25µg Mec
+ was pre-incubated with and without 0.24mM EDTA for 10 
minutes at room temperature.  To the samples, 170µg hisCysO-cysteine and 9.7mM DTT 
were added to a final volume of 155µL in 50mM tris pH8.  The samples were placed at 
37
oC for 1 hour and frozen until analyzed by ESI-FTMS.   
 
3.4.2.5  Substrate specificity of Mec
+:  
CysO-ser:  45µg Mec
+ was added to 198µg CysO-ser, 10µM Zn
2+ and 10mM DTT in 
50mM tris pH8 to a final volume of 150µL.  The sample was incubated at 37
oC for 1 
hour and frozen until analysis by ESI-FTMS.   
 
CysO-cys-ala:  200µg CysO-cys-ala was used in a reaction identical to CysO-ser.   
 
CysO-ala:  39 µg Mec
+ was added to 150µg CysO-ala-cys, 7.5µM Zn
2+ and 7.5mM DTT 
in 50mM tris pH8 to a final volume of 200µL.  The sample was incubated at 37
oC for 1 
hour and frozen until analysis by ESI-FTMS.   
 
CysO-ala-cys:  150µg CysO-ala-cys was used in a reaction identical to CysO-ala.    
 
CysO(G->A)-cys:  150µg CysO(G->A)-cys was used in a reaction identical to CysO-ala. 
 
3.4.2.6  Mec
+ mutagenesis: 
S89A:  37.5µg S89A Mec
+ was added to 200µg hisCysO-cysteine, 7.5mM DTT and 
7.5µM Zn
2+ in 200µL total volume of 50mM tris pH8.  Samples were incubated at 37
oC 
for 1 hour, desalted into bio-spin tris columns, and frozen until analysis by ESI-FTMS.   
 
D101A:  52.5mg D101A was used in a reaction identical to S89A.   
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Chapter 4 
 
 
Conclusion and Outlook 
 
4.1  An Overview 
We’ve shown that a sulfide carrier protein from M. tuberculosis, CysO (Rv1335), in its 
thiocarboxylate form 27, is alkylated to a cysteine adduct 28 by CysM (Rv1336) in the 
presence of O-acetylserine 6.  Following an S-N acyl rearrangement, Mec
+ (Rv1334) 
hydrolyzes the CysO adduct, releasing cysteine 7 and generating CysO-carboxylate 29.  
Preliminary results suggest MoeZ (Rv3206) is responsible for activating CysO through 
adenylation to 30 and sulfur transfer, however, the details of this reaction, including the 
sulfur source, have yet to be established.  We hypothesize that the sulfur source may be 
an intermediate in the sulfate assimilation pathway, or an oxidized form of sulfide.  The 
cysteine biosynthetic pathway is summarized in figure 4.1.   
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Figure 4.1  Cysteine biosynthesis by the new pathway reconstituted from M. tuberculosis.   
 
The new cysteine biosynthetic pathway in M. tuberculosis shares many parallels with 
thiamin and molybdopterin biosyntheses, as well as with ubiquitinylation.  Each pathway 
contains a small protein of less than 100 amino acids that is characterized by two C-
terminal glycine residues.  The activation for sulfide transfer onto these proteins is 
believed to be similar in all cases:  a protein activates the C-terminus first by adenylation, 
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followed by sulfide transfer to form the active thiocarboxylate, or thioester in the case of 
ubiquitin.    The protein-bound thiocarboxylate has been shown to deliver sulfide to 
thiamin, molybdopterin, and now to cysteine.
1,2  In ubiquitin, a sulfur from the activating 
enzyme E1 displaces the activated adenylate.
3   
 
The most intriguing aspect of this cysteine pathway goes beyond the homology of the 
sulfide carrier proteins.  The reaction catalyzed by Mec
+ resembles the deubiquitination 
reaction of the 26S proteasomal subunit Rpn11, which sends doomed proteins into the 
proteasome for degradation and regenerates ubiquitin (figure 1.7).
4  Both Rpn11 and 
Mec
+ contain the JAMM motif, which is found in bacteria, archaea, and eukaryotes 
(figure 3.1).  The proteins are both able to recognize a homologous motif in ubiquitin and 
CysO and catalyze a similar reaction on their substrates, both in completely different 
pathways and biological systems.  These parallels suggest an evolutionary relationship 
between the cysteine pathway in bacteria and the ubiquitin pathway in eukaryotes.   
 
Mycobacterium tuberculosis is one of the most virulent pathogens on record, causing at 
least two million deaths a year.
5  TB can evade the normal immune response and survive 
in the macrophage without being destroyed, remaining dormant in the body for years.  
When TB is engulfed by the macrophage, it is able to prevent phagosome-lysosome 
fusion
6 and can lie dormant until the macrophage is activated.  The metabolism and 
environment of latent TB is poorly understood and current research efforts focus on 
studying latent TB.  TB also has a unique cell envelope that enables the pathogen to resist 
common antibiotics.  Mycolic acid forms a waxy wall around TB and aids in its 
pathogenicity
7,8,9.  Macrophages have developed the method of oxidative stress to defeat 
harmful bacteria.
10  Bacteria are often unable to counteract these reactive oxygen 
intermediates and reactive nitrogen intermediates that are associated with oxidative stress 
and that alter the cellular redox balance.  In addition to latency and the impenetrable 
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envelope, TB expresses proteins which protect the cell from oxidizing conditions in the 
macrophage.
11  Such proteins include the sigma factor discussed in chapter 1, 
thioredoxins, and proteins related to thiol metabolism.
12  We are just beginning to 
understand the unique cellular processes which protect TB from the immune response.  
Identifying genes responsible for the persistence of TB is critical in developing new and 
more affordable treatments against the pathogen.   
 
To survive the harsh conditions of the macrophage, TB must be equipped with the 
appropriate tools, including pathways leading to the upregulation of reductants such as 
thioredoxin and alternate pathways for the biosynthesis of oxygen-sensitive molecules.  
Because cysteine is an essential amino acid for bacteria and it is a substrate for many 
cellular metabolites, it is important that this molecule is still synthesized in the 
macrophage, but little is known about the operable biosynthetic pathway for cysteine in 
TB.  An alternate pathway involving the four genes characterized here, mec
+, cysO, 
cysM, and moeZ, could be responsible for cysteine biosynthesis in TB under oxidative 
stress in the macrophage.  These genes were the only putative cysteine biosynthetic genes 
upregulated under oxidative stress in TB.
12  This cysteine biosynthetic pathway, 
involving a protein-bound thiocarboxylate and not sulfide, could represent a more stable 
source of sulfur for TB under oxidizing conditions; the protein-bound thiocarboxylate is 
less oxygen-sensitive than sulfide and more easily reduced.  
 
4.2  Future directions 
Cysteine is an essential cellular metabolite and bacteria need to biosynthesize it when it is 
not readily available in the environment.  To determine whether TB could survive 
without this cysteine pathway, and to define the environmental conditions that make this 
pathway necessary for TB, the Russell group attempted to knock out, or knock down, the 
pathway in M. tuberculosis.  All attempts to mutate the pathway failed, suggesting its 
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importance for TB growth under the conditions used by the Russell group.  While this 
data is interesting, it does not agree with other reports regarding gene essentiality in 
TB.
13,14  For example, Sassetti used transposon site hybridization (TraSH) to identify 
essential genes for optimal growth in TB and this pathway was not ‘a hit’.
14  
Unfortunately, there is no widely used model system for studying TB, and none of the 
current models are able to reproduce the true growth conditions of TB in the lungs.  This 
makes the interpretation of mutants and gene essentiality studies difficult.  An alternative 
method for defining gene essentiality is through the use of inhibitors.  Developing 
inhibitors for this new pathway will shorten the analysis time compared to traditional 
mutagenesis studies and also enable us to quickly investigate how the pathway functions 
in a variety of growth conditions because we can modulate inhibitor concentration.   
Humans synthesize cysteine using a different pathway, so the inhibitors should be 
specific for the pathway in TB.   
 
Knowledge of protein function provides a solid foundation for which to design inhibitors, 
however, there are certain limits to enzymology which only crystallography is able to 
strengthen.  Obtaining a high resolution crystal structure of the proteins involved in the 
new cysteine biosynthetic pathway enables us to understand the system at a deeper level.  
We can see binding pockets, important loops, and key interactions which we are blind to 
in solution and which directs our inhibitor targeting.  In collaboration with Chris 
Jurgenson and Steve Ealick, the structure of the CysO/CysM complex was solved to 2.1 
Å resolution (unpublished).  The crystal structure of the CysO/CysM complex enables us 
to gain insight into the design and development of molecules that would disrupt this 
interaction and thus inhibit cysteine biosynthesis.  For example, we can infer from the 
crystal structure that the crucial interaction between CysM and CysO is at the C-terminus 
of CysO, encompassing the last third of the protein.  Development of a peptide mimic of 
the C-terminus of CysO, encompassing the minimal binding region to CysM, may be a 
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good starting point for inhibitor design.  Similarly, the structure of the complex suggests 
that the diglycyl C-terminus of CysO is curved, unlike most sulfide carrier proteins.  This 
feature provides extra space in the CysM active site, a feature which should be exploited 
in inhibitor design.  Future work will focus on the design, synthesis and development of 
inhibitors of the CysO/CysM interaction, all guided by the crystal structure of the 
complex.   
   
Future studies on this cysteine biosynthetic pathway will also focus on kinetic 
characterization of the system.  How fast does CysO-thiocarboxylate 27 react with the 
CysM-α-aminoacrylate intermediate 26 and how does this compare to sulfide and other 
sulfur-containing compounds?  TB grows very slowly:  does the reaction rate parallel the 
growth rate of TB?  Investigating the kinetics of this pathway will also enable us to 
design better inhibitors, and enable us to probe the inhibition.   
 
Finally, we’d like to explore the mechanism and substrates for sulfide transfer by MoeZ 
in more detail.  We were able to observe thiocarboxylate formation on CysO when the 
two proteins were co-purified from E. coli, however, not when the proteins were purified 
separately.   It could be that the system requires protein stabilization for activity.  This 
was tested in an additional experiment where the small molecules were removed from the 
cell lysates of CysO and MoeZ prior to combining them.  No thiocarboxylate was 
formed.  Interestingly, addition of ATP and sulfide back to this desalted mixture restored 
thiocarboxylate formation.  In the pure system, this reaction did not work.  It is possible 
that sulfide is modified in E. coli crude cell lysates, and MoeZ is able to use the modified 
sulfide as a substrate.  It would be interesting to determine if MoeZ is modified by sulfide 
in any way, as is observed for similar proteins.
15  To determine the source of sulfur and to 
reconstitute thiocarboxylate formation in a purified system will require careful and in 
depth analysis of these experiments as well as others.   
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 Chapter 5 
 
 
Vitamin B6 Biosynthesis 
 
5.1  Vitamin B6:  An introduction 
Vitamin B6 is an essential cofactor in all living systems.  The cofactor aids in amino acid 
and carbohydrate metabolism and has recently been implicated in singlet oxygen 
resistance.
1  Pyridoxine, pyridoxamine, pyridoxal and their phosphates are collectively 
termed vitamin B6, however, pyridoxal-5’-phosphate (PLP; 1) is the active form of the 
cofactor (figure 5.1). 
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Figure 5.1  The three forms of vitamin B6 found in the cell, shown here in their 
phosphorylated forms.   
 
PLP covalently attaches to enzymes through a Shiff base (imine) with an active site 
lysine.  This attachment positions the cofactor in the active site and activates the PLP 
aldehyde for a transimination reaction, which is faster than an imination so the reaction 
with the substrate is fast.
2  In all enzymes for which it is a cofactor, PLP 1 covalently 
links to the substrate via an imine.  The cofactor acts as an electrophilic catalyst that 
stabilizes carbanions via its electron deficient pyridine ring.
3  From transaminations to 
dehydrations and eliminations, this coenzyme increases the breadth of reactions available 
in nature.  The enzyme commission has identified more than 140 different activities that 
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depend on PLP, constituting 4% of classified enzyme activities.  In prokaryotes, almost 
1.5% of the genes encode for PLP-utilizing enzymes, highlighting its importance in basic 
metabolism.
4   
 
Humans obtain vitamin B6 from their diet; we are unable to synthesize our own. Bacteria, 
fungi, protozoa, archaea and plants provide the B6 found in nature, and we depend on 
these resources for our supply.  Importantly, many pathogens are able to synthesize PLP 
de novo, and vitamin B6 biosynthesis, and vitamin biosynthesis in general, is an attractive 
target for antibiotics and antifungals.  To optimize dietary consumption of vitamin B6 
and to identify potential drug leads, it is critical to understand the enzymes involved in its 
biosynthesis.   
 
5.2  Salvage and E. coli de novo Vitamin B6 pathways 
Three pathways exist for PLP formation:  the salvage pathway and two distinct de novo 
pathways.  The salvage pathway involves the uptake of pyridoxine 2 into the cell, 
followed by phosphorylation by PdxK and oxidation to the aldehyde PLP 1 by PdxH 
(Figure 5.2).  The de novo biosynthesis of PLP  has been well characterized in 
Escherichia coli.
5-11  It involves six enzymes, four of which are unique to PLP 
biosynthesis.  GapA and PdxB perform sequential NAD-dependent oxidations on D-
erythrose-4-phosphate 3, which is followed by amine transfer from glutamate catalyzed 
by PdxF.  The product 4-phosphohydroxy-L-threonine 4 is then decarboxylated by PdxA 
to form 3-hydroxy-1-aminoacetone-3-phosphate 5, which combines with 1-
deoxyxylulose-5-phosphate 6 (from 1-deoxyxylulose-5-phosphate synthase) in a reaction 
catalyzed by PdxJ.  The product of the PdxJ reaction, pyridoxine-5’-phosphate 7, is 
oxidized to PLP 1 by PdxH.     49
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Figure 5.2  The E. coli de novo PLP biosynthetic pathway and the salvage pathway for 
PLP biosynthesis.  The de novo pathway involves enzymes GapA, PdxB, PdxF, PdxA, 
PdxJ, and PdxH.  The salvage pathway involves PdxK and PdxH.   
 
5.3  Alternate de novo Vitamin B6 biosynthetic pathway:  PLP 
synthase 
It had been observed that many organisms, including yeast and bacteria such as Bacillus 
subtilis, do not contain homologs of the Pdx genes found in E. coli.
12,13  Labeling studies 
in yeast suggested an alternate pathway exists for B6 biosynthesis; this pathway 
incorporates an intact five carbon sugar, an intact three carbon sugar, as well as the amide 
nitrogen of glutamine into vitamin B6 (figure 5.3).
14-16  Neither the oxidation state nor the 
phosphorylation state of the substrates and B6 product was known.  Mutagenesis 
implicated a highly conserved gene, SNZ (YaaD in B. subtilis), as well as a glutaminase 
SNO (YaaE in B. subtilis), in the biosynthesis of vitamin B6 in these organisms.
12, 13, 17  It 
was suggested that YaaD served as the PLP synthase subunit and YaaE provided the 
ammonia needed for the pyridine ring.   
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Figure 5.3  Labeling studies suggest a five carbon sugar, a three carbon sugar and the 
amide nitrogen of glutamine form the backbone of vitamin B6 in yeast.   
 
YaaD and YaaE are found clustered in many organisms, and in contrast to the E. coli 
pathway, which has only been identified in bacteria, the YaaD and YaaE genes are 
present in bacteria as well as fungi, yeast, plants, some metazoa and archaea.  The two 
pathways are also mutually exclusive:  they do not coexist in any organism that has been 
sequenced to date.  A few of these organisms are shown in Table 5.1.
18,19   
 
The sequence of YaaE suggests it belongs to the class I triad amidotransferase family, 
where highly conserved active site histidine, glutamine and cysteine residues hydrolyze 
ammonia from the amide of glutamine to form glutamate.
20  Addition of acivicin 
irreversibly inhibits these glutaminases through labeling of the active site cysteine, 
suggesting a covalent intermediate is part of the mechanism, which is shown in figure 5.4 
20.  The structure of the amidotransferase YaaE from B. subtilis was solved in 2004 at 2.5 
Å,
21 and shortly thereafter amidotransferase activity had been reconstituted in both B. 
subtilis
17 and S. cerevisiae.
22  These studies confirm the glutaminase activity of YaaE 
both structurally and biochemically. 
 
 
   51
Table 5.1  Mutual exclusiveness of the PLP biosynthetic pathways.   
Organism (selected subset)  YaaD/E 
(B. subtilis) 
PdxA/J 
(E. coli) 
Plants                      A. thaliana  +  - 
                               O. sativa  +  - 
Fungi                      S. cerevisiae  +  - 
                               A. nidulans  +  - 
                               C. albicans  +  - 
Archaebacteria       M. jannaschii  +  - 
                               P. abyssi  +  - 
                               A. fulgidus  +  - 
Eubacteria              B. subtilis  +  - 
                              M. tuberculosis  +  - 
                              T. maratima  +  - 
                              E. coli  -  + 
                              H. pylori  -  + 
                              B. cepacia  -  + 
                              P. aeruginosa  -  + 
                             V. chlorea  -  + 
+ indicates the presence of the genes; - indicates the absence. 
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Figure 5.4  General mechanism for class I glutamine amidotransferases (GAT).  A 
catalytic cysteine residue forms a covalent adduct with the substrate, which releases 
ammonia.  The covalent adduct is eventually hydrolyzed.   
 
Most amidotransferases have two domains, a GAT domain (glutamine amidotransferase 
domain) and a synthase domain.  The GAT domain forms ammonia which travels 
through a tunnel connecting the active sites of the two domains.  The synthase domain 
catalyzes the ammonia-dependent reaction.  Where GAT domains are often very similar, 
the synthase domains differ greatly depending on the system.
20  Amidotransferases are 
found in histidine, tryptophan, arginine and purine biosyntheses,
20 all of which produce 
very different molecules.  YaaD is the synthase subunit of PLP synthase.  When 91 
sequences of YaaD were aligned, all pairs of sequences (including sequences from 
archaea, prokaryotes and eukaryotes) shared at least 60% identity.
23  Due to its high 
sequence conservation, shown in figure 5.5, very little reaction information can be gained 
from a Psi-BLAST search.  The one protein that shows up besides YaaD is thiazole 
synthase ThiG, a protein that forms an imine with the substrate 1-deoxyxylulose-5-
phosphate prior to thiazole formation.  The imine is cleaved by an intramolecular 
transimination later in the reaction sequence.
24  Analogous imine formation with a 5-
carbon sugar substrate was a reasonable possibility for the YaaD catalyzed PLP reaction. 
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The structural model of YaaD shows a high level of similarity to  imidazole 
glycerolphosphate synthase (HisF),
21 the enzyme that catalyzes the formation of the 
imidazole ring of histidine.  One of the steps catalyzed by this enzyme involves an amine 
addition (from HisH GAT domain) to the C2 carbonyl of a 1-amino-ribulose-5-phosphate 
analog (figure 5.6).
25  This similarity suggested that YaaD might also catalyze an amine 
addition (from YaaE) to the carbonyl group of a 5-carbon sugar.  
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Figure 5.6  Reaction catalyzed by HisF in histidine biosynthesis.   
 
Chapters 6-9 will describe the identification of the substrates for PLP synthase, describe 
the reconstitution of the pathway in a defined system, outline a mechanism for the 
transformation, and discuss efforts at developing inhibitors and mutants of the PLP 
synthase complex.   
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 Chapter 6 
 
 
Reconstitution and identification of three partial reactions of PLP 
synthase
i
 
6.1  Introduction 
Although labeling studies in yeast suggested that the backbone of vitamin B6 was formed 
with an unidentified five carbon sugar,
1 an unidentified three carbon sugar
2 and the amide 
nitrogen of glutamine,
3 the reaction of YaaE and YaaD had not been reconstituted.  This 
chapter confirms the identity of the substrates as ribose-5-phosphate, glyceraldehyde-3-
phosphate and glutamine, and the product as pyridoxal-5’-phosphate (PLP; 1).  Three 
surprising partial reactions for the synthase subunit of PLP synthase will also be 
described.   
 
6.2  Results and discussion 
 
6.2.1  Expression of YaaD and YaaE 
B. subtilis YaaD and YaaE express as insoluble protein in LB media.  The best way to 
express them is in Tuner(DE3) cells in M9 minimal media with addition of glucose, 
MgSO4 and CaCl2.  Expression can be done at 37
oC for 5 hours or at reduced temperature 
for extended times.  YaaD and YaaE need to be purified in buffer above pH7.5.   
Purification into more acidic buffers causes the proteins to precipitate.  A gel of purified 
YaaD and YaaE is shown in figure 6.1.   
                                                 
i Reproduced in part with permission from Burns, K.; Xiang, Y.; Kinsland, C.; McLafferty, F.; Begley, T. 
(2005) J. Am. Chem. Soc. 127, 3682-3683. 
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Figure 6.1  15% SDS-PAGE of soluble and pure samples of YaaD and YaaE from B. 
subtilis.  From the right:  lane 1, MW markers; lane 2, YaaD soluble protein; lane 3, pure 
YaaD; lane 4, YaaE soluble protein; lane 5, pure YaaE.  
  
6.2.2  YaaE glutaminase activity 
To determine if the amidotransferase subunit of PLP synthase from B. subtilis, YaaE, is 
able to hydrolyze glutamine to glutamate, thin layer chromatography (TLC) was used 
with dansyl chloride as the visualization agent.  When YaaE was incubated with 
glutamine in buffer, no glutamate was observed by TLC.  When YaaD was added to the 
reaction, however, glutamine was converted to glutamate.  This suggested that YaaD is 
needed to activate YaaE for hydrolysis of glutamine.  This dependence on a binding 
partner is not unusual for glutaminases; it would be harmful to have ammonia released 
randomly in the cell.
4  These results are consistent with previous studies with YaaE
5,6 and 
confirm that our YaaE was active and most likely forming a complex with YaaD.   
 
6.2.3  Covalent modification of YaaD   
As mentioned above, YaaD activates the amidotransferase activity of YaaE:  when YaaD, 
YaaE and glutamine are combined, glutamate formation is observed using dansyl 
chloride.  In addition, we also observe an increase in absorbance at 320nm.  Because the   59
absorbance was not dependent on the addition of either the 5-carbon sugar or the 3-
carbon sugar, we proposed there may be some substrate pre-bound to YaaD and that a 
reaction between YaaE, glutamine and YaaD with pre-bound substrate causes this 
absorbance increase.  ESI-FTMS (in collaboration with Yun Xiang and Fred McLafferty) 
analysis of freshly isolated YaaD demonstrated the presence of unmodified YaaD (34209 
Da) as well as an adduct (34421 Da) that was 212 Da heavier than native YaaD.  The 
mass spectrum is shown in figure 6.2a.  The mass of this adduct is consistent with that 
expected for a YaaD-pentulose phosphate imine.  To confirm this, ribulose-5-phosphate 8 
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Figure 6.2  ESI-FTMS of freshly purified YaaD  a.  YaaD as isolated  b.  Ribulose-5-
phosphate treated YaaD  c.  Reaction catalyzed by YaaD.  
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was added to YaaD and most of the unmodified YaaD was converted to the adduct, as 
shown in figure 6.2b.  This suggests that ribulose-5-phosphate 8 is the bound 
carbohydrate and it is either a substrate or an intermediate in the PLP synthase reaction, 
as proposed in figure 6.2c.  This reaction is similar to that catalyzed by thiazole synthase 
ThiG in thiamin biosynthesis (substrate is 1-deoxyxylulose phosphate).
7 
 
MS-MS analysis of the YaaD adduct localized the imine to lysine 149, which is 
absolutely conserved in the YaaD family of proteins.  The results were confirmed by 
demonstrating that the K149A mutant did not form an adduct with ribulose-5-phosphate, 
suggesting that the YaaD-ribulose-5-phosphate imine adduct 9 is an intermediate in the 
PLP synthase reaction.  A recent structure of YaaD from Geobacillus stearothermophilus 
at 2.2Å shows that lysine 149 is pointing away from the active site of YaaD and rotation 
about the peptide bond positions it nicely for imine formation with ribulose-5-phosphate.
8   
 
6.2.4  YaaD isomerization of ribose-5-phosphate  
Treatment of YaaD with ribulose-5-phosphate 8 yielded a 212 Da adduct on YaaD.   
Interestingly, ribose-5-phosphate 10, an isomer of ribulose-5-phosphate 8, could also 
form this adduct.  The observation that the YaaD adduct could be reconstituted with 
equal ease from both ribulose-5-phosphate 8 and ribose-5-phosphate 10 suggested that 
YaaD catalyzed the interconversion of these two compounds. This was confirmed by 
NMR analysis of a reaction mixture containing ribose-5-phosphate 10 and YaaD, which 
is shown in figure 6.3a.  Signals with chemical shifts at 3.75 (m, 2H, H5), 3.88 (m, 1H, 
H4) and 4.29 (d, J=5.8Hz, 1H, H3) confirm the formation of ribulose-5-phosphate.  This 
suggests that YaaD has ribose-5-phosphate isomerase activity (figure 6.3b). 
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Figure 6.3  Ribose-5-phosphate 10 isomerization by YaaD  a.  
1H NMR of the YaaD-
catalyzed isomerization of ribose-5-phosphate 10 to ribulose-5-phosphate 8.  * indicate 
signals from ribulose-5-phosphate 8.  The triplet at 4.16 (H2 of ribulose-5-phosphate 8) 
collapses to a doublet due to deuterium exchange at C1  b.  Isomerization reaction 
catalyzed by YaaD.   
 
6.2.5  Reconstitution of PLP biosynthesis       
While previous labeling studies did not identify the triose precursor to carbons 5, 5’ and 6 
of PLP,
2 dihydroxyacetone phosphate or glyceraldehyde-3-phosphate were the most 
likely precursors and the stage was now set for attempting the in vitro reconstitution of 
the biosynthesis. In the event, when ribulose-5-phosphate 8, dihydroxyacetone phosphate 
11 and glutamine were incubated with PLP synthase, the reaction mixture turned yellow 
after 30 minutes at 37
oC and showed a UV-visible spectrum with an absorbance 
*
*
*
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maximum at 390 nm, similar to that in figure 6.4a.  HPLC analysis demonstrated the 
formation of two reaction products that comigrated with PLP and pyridoxal (PL) 
standards (figure 6.4b) (note that tris buffer catalyzes the dephosphorylation of PLP after 
extended periods).  A sample for NMR analysis was generated by treating the reaction 
mixture with alkaline phosphatase, followed by HPLC purification.  Signals with 
chemical shifts of 2.35 (s, 3H, H2’), 4.86 (d, J=14.2Hz, 1H, H5’), 5.10 (d, J=14.2Hz, 
1H, H5’), 6.41 (s, 1H, H6) and 7.45 (s, 1H, H4’) unambiguously identified the isolated 
product as pyridoxal hemiacetal.  The NMR is displayed in figure 6.4c.  
 
The rate of formation of PLP, under various conditions, was monitored by measuring the 
absorbance increase at 390 nm (figure 6.5).  Both ribulose-5-phosphate 8 and ribose-5-
phosphate 10, as well as glyceraldehyde-3-phosphate 12 and dihydroxyacetone phosphate 
11, are substrates for PLP synthase.  The absorption at 390 nm is dependent on the YaaD 
concentration.  Although purification of YaaD and YaaE requires higher pHs for stability, 
the optimal pH for the PLP synthase reaction is 6-6.5.  The initial lag of about 3 minutes 
is observed with all substrates so substrate isomerization does not play a role in the lag. 
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Figure 6.4  Reconstitution of PLP biosynthesis  a.  UV-Vis absorbance spectrum of the 
PLP synthase reaction with YaaD, YaaE, glutamine, ribulose-5-phosphate 8 and 
dihydroxyacetone phosphate 11  b.  HPLC of the PLP synthase reaction containing the 
same components  c.  
1H-NMR of phosphatase treated and HPLC-purified reaction 
product.   
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Figure 6.5.  Rate of formation of PLP under various conditions.  Ribose-5-phosphate 10 
and glyceraldehyde-3-phosphate 12 (A); ribulose-5-phosphate 8 and glyceraldehyde-3-
phosphate 12 (B); ribose-5-phosphate 10  dihydroxyacetone phosphate 11  (C); ribulose-
5-phosphate 8 and dihydroxyacetone phosphate 11 (D). 
 
6.2.6  YaaD catalyzed isomerization of dihydroxyacetone phosphate  
The observation that dihydroxyacetone phosphate 11 and glyceraldehyde-3-phosphate 12 
were both substrates suggested that PLP synthase also has triose phosphate isomerase 
activity.  To test this, we incubated dihydroxyacetone phosphate 11 with YaaD in 
deuterated buffer.  NMR analysis of this sample indicated that YaaD catalyzed partial H-
D exchange at C-1 of dihydroxyacetone phosphate 11, and no glyceraldehyde-3-
phosphate 12 was detected.  The NMR is shown in figure 6.6a.  The triplet partially 
overlapping the C-3 doublet corresponds to the single proton at C-1 of dihydroxyacetone 
phosphate  11 after the stereospecific isomerization reaction.
9  The absence of 
glyceraldehyde-3-phosphate  12 from the reaction mixture is not unexpected as the 
equilibrium constant lies in favor of dihydroxyacetone phosphate 11.
10  In addition, triose 
phosphate isomerase activity was confirmed when we detected the formation of 
dihydroxyacetone phosphate 11 from YaaD and glyceraldehyde-3-phosphate 12 by 
NMR.  This suggests that YaaD has triose phosphate isomerase activity, which is shown 
in figure 6.6b.     65
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Figure 6.6  Dihydroxyacetone phosphate (DHAP; 11) isomerization by YaaD  a.  
1H NMR 
of the YaaD-catalyzed isomerization of dihydroxyacetonephosphate 11.  * indicates the 
H-D exchange of the C1 proton and the arrow shows the triplet that results from the 
proton left after the stereospecific isomerization   b.  Isomerization reaction catalyzed by 
YaaD.   
 
6.2.7  Kinetics of PLP synthase 
Because cofactors aren’t needed in huge quantities in the cell, their biosyntheses are 
relatively slow.
11  It is clear that this is the case for PLP synthase as well.  As indicated in 
figure 7.5, PLP synthase has a lag in the formation of PLP.  We wanted to get a better 
idea of the overall kinetics of the PLP synthase reaction.  In addition, kinetics would 
allow us to ascertain the true substrates among the isomers.  The kinetics were obtained 
by monitoring the formation of PLP at 390nm with time.  The Km for glutamine in the 
PLP synthase reaction is 115±17μM (with ribose-5-phosphate 10 and glyceraldehyde-3-
phosphate 12); dihydroxyacetone phosphate 11 is 119±17μM (with ribose-5-phosphate 
10); glyceraldehyde-3-phosphate 12 is 56±5μM (with ribose-5-phosphate 10); ribose-5-
phosphate 10 is 30±5μM (with glyceraldehyde-3-phosphate 12).  The turnover number   66
(kcat) averaged 0.05min
-1.  These numbers compare well with those recently published for 
B. subtilis PLP synthase 
12.   
 
Older literature suggests that YaaD is guanylylated in vivo.
13,14  Confirmation of 
guanylylation and its purpose have yet to be established.  It is possible that this or other 
cellular modifications could modulate PLP synthase activity, making it more or less 
active at certain stages of cell growth.  To determine whether a modification or other 
proteins are needed to increase or alter PLP synthase activity, PLP synthase was 
incubated in both B. subtilis and E. coli crude cell lysates and analyzed for activity.  
Neither B. subtilis nor E. coli cell lysates were able to increase PLP synthase activity 
beyond that in the purified system, and the lag was still present.   
 
6.3  Conclusion 
We have demonstrated the first successful reconstitution of PLP synthase from the YaaE 
and YaaD family of genes in B. subtilis.  Glutamine, ribose-5-phosphate 10 or ribulose-5-
phosphate 8, and glyceraldehyde-3-phosphate 12 or dihydroxyacetone phosphate 11 are 
the substrates, and the product was identified as pyridoxal-5’-phosphate 1.  YaaE 
hydrolyzes glutamine to glutamate and ammonia, and ammonia travels to the active site 
of YaaD.  Glutaminase activity depends on the presence of YaaD.  In addition to 
catalyzing PLP formation, we have identified three partial reactions catalyzed by YaaD in 
the transformation to PLP:  isomerization of ribose-5-phosphate 10 and ribulose-5-
phosphate  8; isomerization of dihydroxyacetone phosphate 11  and glyceraldehyde-3-
phosphate 12; and imine formation with ribulose-5-phosphate 8 and lysine 149.  The 
kinetics of the PLP synthase reaction suggest the enzymes are slow, and the best 
substrates are ribose-5-phosphate 10, glyceraldehyde-3-phosphate 12, and glutamine.   
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6.4  Experimental procedures 
 
6.4.1  Materials and methods 
 
6.4.1.1  Materials:  pET28a vector was from Novagen, restriction enzymes from New 
England Biolabs, primers were ordered from BioResource Center at Cornell University.  
A Perkin Elmer GeneAmp PCR System 2400 was used for PCR and mutagenesis.  Pfx 
Platinum polymerase was from Invitrogen.  QiaExII gel extraction kit and PCR 
purification kit were purchased from Qiagen, and miniprep kit was from Promega.  T4 
DNA ligase was purchased from New England Biolabs.  Clones were sequenced at the 
Bioresource Center at Cornell University.  DH5α was used for propagation and storage; 
BL21(DE3) for overexpression; both were purchased from Novagen.  Ni-Nta resin was 
from Qiagen and all chemicals were purchased from Sigma.  DG10 desalting columns 
were purchased from BioRad, Centricon ultra concentrators were from Amicon, as were 
the microcon concentrators.  
 
6.4.1.2  Cloning, overexpression and purification of YaaD and YaaE 
(YaaD.28; YaaE.28):  (Done by Cynthia Kinsland)  B. subtilis CU1065 genomic DNA 
was amplified using the following primers:  YaaD 5’for-TAG GGG GAC CAA CAT 
ATG GCT CAA ACA GGT ACT GAA CG-3’; 5’rev-TTG TTA ACA TGT CTC GAG 
CGC TCC TAT GTT CTT ACC AGC-3’; YaaE 5’for-AGG AGC GCT GCT CAT ATG 
TTA ACA ATA GGT GTA CTA GG-3’; YaaE 5’for-CTA TCA ACG CTT CTC GAG 
CTT TAT TTG TGC TTA TAA TG-3’.  NdeI and XhoI restriction sites were added to 
the forward and reverse primer, respectively.  The gene was amplified using Pfx Platinum 
DNA polymerase with a 1.5min extension time.  Upon purification of the PCR fragment 
from the agarose gel, the product and the pET28a vector were cut with NdeI and XhoI.  
Digested pET28a was treated with CIP.  The cut pET28a vector and cut PCR product   68
were purified by gel and ligated with T4 ligase at room temperature for 2 hours.   
Competent DH5α cells were transformed with 2.5μL of the ligation mixture and plated 
on LB-Kan plates.  Colonies were checked for insert by colonly PCR.  Colonies with 
insert were sequenced.   
 
E. coli Tuner(DE3) cells were used for protein expression.  Cells were grown to an 
OD600 of 0.5 and induced with 1mM IPTG at 37
oC.  After 5 hours of induction, the cells 
were harvested at 8,000 rpm for 10 minutes and stored at -20
oC until purification.   
 
Cells containing overexpressed protein were resuspended in lysis buffer (50mM 
phosphate pH9, 300mM NaCl, 10mM imidazole) with lysozyme.  The cells were lysed 
by sonication (30-2 second pulses, 3 times), and the cell debris was removed by 
centrifugation for 30minutes at 17,000 rpm.  The cleared lysate was passed through pre-
equilibrated (with lysis buffer) Ni-Nta resin.  Following a quick wash with lysis buffer, 
the resin was washed with wash buffer (50mM phosphate pH8, 300mM NaCl, 20mM 
imidazole) until little protein eluted by Coommassie.  When little protein washed off, 
protein was eluted with elution buffer (50mM phosphate pH8, 300mM NaCl, 250mM 
imidazole), desalted into 25mM phosphate pH8 using DG10 desalting columns, and 
concentrated.  Typical yield for 1L of culture was 10 mg for YaaD and 20mg for YaaE. 
 
6.4.2  Assays 
 
6.4.2.1  Materials:  All chemicals were purchased from Sigma.  ESI-FTMS was 
performed by the McLafferty group at Cornell University.  NMR spectra were obtained 
on an INOVA 600MHz spectrometer, UV-Vis spectra were obtained on a Hitachi U2010 
spectrophotometer and HPLC was performed on a Hewlett Packard 1100 Series   69
instrument.    Microcons were purchased from Amicon and HPLC column was from 
Supelco.   
 
6.4.2.2  YaaE glutaminase activity: 
34μg YaaD, 80μg YaaE and 10mM glutamine were incubated in 50mM Tris, pH8 at 
room temperature.  After 30 minutes, 10μL of the sample was added to 30μL dansyl 
chloride solution (10mM dansyl chloride in actone).  The pH was adjusted to 9.5 with the 
addition of 0.6μL 0.3M NaOH.  After 30 minutes, 5μL was spotted on Si coated TLC 
plates, it was allowed to dry, and then developed in chloroform:  t-butanol:  acetic acid 
(6:3:1).  Controls omitted enzyme, YaaD, and used glutamate in place of glutamine.   
 
6.4.2.3  Covalent modification of YaaD: 
A typical reaction contained 200μg YaaD and 10mM ribose-5-phosphate (or ribulose-5-
phosphate) in 50mM phosphate, pH8.  After 1 hour at 37
oC, the sample was frozen for 
ESI-FTMS analysis.   
  
6.4.2.4  YaaD isomerization of ribose-5-phosphate: 
1mg YaaD and 3mM ribose-5-phosphate were combined in 50mM deuterated phosphate, 
pD 7.8.  Isomerization was observed using a 600MHz NMR.   
 
6.4.2.5  Reconstitution of PLP biosynthesis:       
UV:  25μg YaaD, 25μg YaaE, 5mM ribulose-5-phosphate, 5mM dihydroxyacetone 
phosphate and 5mM glutamine were combined in 50mM phosphate, pH8 in 400μL total.  
Blank contained no dihydroxyacetone phosphate.  Wavelength scans were taken every 
few minutes with a UV-Vis spectrometer.   
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HPLC:  1mg YaaD and 1mg YaaE were incubated with 1mM ribulose-5-phosphate, 
4mM dihydroxyacetone phosphate and 5mM glutamine in 1mL total.  After 15 hours at 
37
oC in the dark, the samples were lyophilized to about 250μL and protein removed with 
microcon concentrators.  Samples were analyzed by HPLC with a LC-18-T column, 
15cm x 4.6mm, 3μm with the following solvent system:  A, water; B, 100mM KH2PO4 
pH6.6; C, methanol.  0-6minutes, 100% B; 7minutes, 10% C; 20minutes, 30% C, 30% A; 
22minutes, 100% B.   
 
NMR:  3.8mg YaaD, 1.6mg YaaE, 1mM ribulose-5-phosphate, 5mM dihydroxyacetone 
phosphate and 5mM glutamine were combined in 50mM phosphate, pH8 in 1.5mL total.  
After 16 hours at 37
oC in the dark, 0.5mg Alkaline phosphatase and 1mM MgSO4 were 
added and allowed to sit for 1.5 hours at 37
oC.  Following a little lyophilization to reduce 
the volume, the protein was removed with microcon concentrators and all of the sample 
was injected into the HPLC (using the same method described above).  The pyridoxal 
peak at 8 minutes was collected, lyophilized, and analyzed on a 600MHz NMR.   
 
6.4.2.6  YaaD isomerization of dihydroxyacetone phosphate: 
H/D exchange:  80μg YaaD was incubated with 2.7mM dihydroxyacetone phosphate in 
50mM phosphate, pD7.0.  Isomerization was observed using a 600MHz NMR.   
 
Dihydroxyacetone phosphate formation:  420μg YaaD was incubated with 2.7mM 
glyceraldehyde-3-phosphate in 50mM phosphate, pD7.5.  Dihydroxyacetone phosphate 
was observed using a 600MHz NMR.   
   
6.4.2.7  Kinetics of PLP synthase: 
In 320μL total, 150μg YaaD and 150μg YaaE were added to 5mM ribose-5-phosphate 
and 5mM glyceraldehyde-3-phosphate in 30mM phosphate, pH6.6 with various   71
concentrations of glutamine (100μM – 2.5mM).  The reactions were monitored at 390nm 
at room temperature.  Initial rates were plotted vs. substrate concentration to determine 
Vmax, Km and kcat values.  Similar analysis was done on each substrate.   
 
E. coli crude cell lysate:  250μL crude cell lysate from YaaD overexpression strain BL21 
and 250μL crude cell lysate from YaaE overexpression strain BL21 was mixed with 
3mM ribose-5-phosphate, 3mM glyceraldehyde-3-phosphate and 3mM glutamine in 
550μL total.  Absorbance at 390nm was monitored with time.   
 
B. subtilis crude cell lysate:  B. subtilis TX1 cells were grown in LB supplemented with 
0.1% glucose, 13.4mM KCl, 20μM MnCl2, 1μM FeSO4, 1mM MgSO4 and 1mM CaCl2 
at 37
oC.  After 8 hours, the cells were harvested and stored at -20
oC until use.  A cell 
pellet from 300mL culture was resuspended in 25mL buffer (0.1M HEPES, pH7.5; 2mM 
PMSF; 0.5mg/mL lysozyme) and incubated at 37
oC for 10 minutes.  The sample was 
cooled on ice and sonicated 8 times with 30 second intervals with 80/120 mesh glass 
beads.  The cell debris was collected at 10,000xg for 10 minutes.  The 25mL was added 
to 25mL assay buffer, which included 25mM tris, pH7.8, 1mM β-mercaptoethanol, 
100mM NaCl, 2mM MnCl2, 20μM GTP and 20μM ATP.  To this, 600μg YaaD was 
added and allowed to sit on ice for 25 minutes.  200μL of this mixture was added to 75μg 
YaaE, 4.7mM ribose-5-phosphate, 4.7mM dihydroxyaceteone phosphate and 4.7mM 
glutamine in 360μL total and the absorbance at 390nm was measured with time.  After 
25minutes, the sample was added to pre-equilibrated Ni-Nta resin.  The sample was 
purified according to the normal protocol for YaaD.  Purified YaaD activity was tested 
with 150μg YaaD, 150μg YaaE, 4.8mM ribose-5-phosphate, 4.8mM dihydroxyacetone 
phosphate and 4.8mM glutamine in 50mM phosphate, pH6.6, 360μL total.   
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 Chapter 7 
 
 
Mechanistic Studies on PLP synthase 
 
7.1  Introduction 
The alternate PLP biosynthetic pathway involving YaaD and YaaE is present in 
pathogens such as Mycobacterium tuberculosis and Plasmodium falciparum, making it an 
attractive drug target in these organisms.  In order to design and synthesize effective 
inhibitors against PLP synthase, it is necessary to first understand the mechanism of PLP 
formation.  Mechanistic analysis of PLP synthase will enable us to envision substrate 
analogs and intermediate analogs which could serve as potential inhibitors.   
 
Unlike the E. coli de novo pathway, the alternate PLP biosynthetic pathway involves only 
two enzymes (YaaD and YaaE), and it appears that the majority of the chemistry is 
performed by YaaD, the synthase subunit.  Chapter 6 characterized the substrates of the 
PLP synthase reaction as well as three partial reactions catalyzed by YaaD.  This chapter 
will describe the steps immediately following pentose isomerization and adduct 
formation on YaaD, including the first bond forming reaction and the formation of a 
stable intermediate. 
   
7.2  Results and Discussion 
 
7.2.1  Ribose-5-phosphate-ammonia bond formation 
To probe the early steps of the PLP synthase reaction,  we decided to monitor the reaction 
using mass spectrometry (in collaboration with Yun Xiang and Fred McLafferty).  YaaD 
purifies with a covalent imine adduct 9 of MW 34421 Da with the addition of ribose-5-
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phosphate 10 or ribulose-5-phosphate 8 (figure 7.1a).  If C-C bond formation between 
ribose-5-phosphate  10 and dihydroxyacetone phosphate 11 or glyceraldehyde-3-
phosphate 12 occurs first to form the carbon backbone of PLP, we would expect to see a 
higher molecular weight species by mass spectrometry when triose is added.  When 
dihydroxyacetone phosphate 11, ribulose-5-phosphate 8 and YaaD were mixed, no 
additional adduct is observed on YaaD; we only observe the ribulose-5-phosphate adduct 
9.  We then hypothesized that the ammonia generated from the hydrolysis of glutamine 
by YaaE may add to the YaaD-ribulose-5-phosphate imine 9 to release the enzyme-bound 
adduct.  When YaaE and glutamine were mixed with YaaD and ribulose-5-phosphate 8, 
we observe the release of the adduct from YaaD, forming apo-YaaD with MW 34209 Da.  
The mass spectrum is shown in figure 7.1b.  The reaction depends on glutamine; YaaE 
alone cannot release the adduct from YaaD.  This result suggests that in the absence of 
the triose, a transimination reaction occurs with ammonia and the YaaD-ribulose-5-
phosphate adduct 9, and this transimination releases the covalent adduct from YaaD to 
produce a pentulose-imine intermediate 13, which is shown in figure 7.1c.  The first bond 
formed in the PLP synthase reaction is between ammonia and the C2 of ribose-5-
phosphate  10.  This reaction resembles that of imidazole glycerolphosphate synthase 
(HisF), the enzyme with structural homology to the YaaD model proposed by Bauer.
1  
HisF produces the imidazole ring of histidine and is shown in figure 5.6.
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Figure 7.1 ESI-FTMS of the partial PLP synthase reaction  a.  YaaD incubated with 
ribose-5-phosphate  10  b.  YaaD incubated with ribose-5-phosphate 10, YaaE and 
glutamine  c.  Transimination releases the pentulose covalent adduct from YaaD.   
 
7.2.2  Intermediate formation 
To determine whether the pentulose phosphate imine 13 is further processed in the 
absence of the triose, we monitored the reaction by UV-Vis spectrophotometry.  As 
displayed in figure 7.2a, the PLP synthase reaction in the absence of triose shows an   76
absorbance at 320nm, which is dependent on the enzyme concentration and time.   
Addition of dihydroxyacetone phosphate 11 to the intermediate results in an isosbestic 
point at 340nm (figure 7.2b), and while the intermediate approaches the steady state 
level, product PLP 1 (measured by its absorbance at 410nm) increases linearly with time 
(figure 7.2c).  This suggests that the absorbance that we observe at 320nm is an 
intermediate and that it is converted to PLP 1.  The intermediate appears to be tightly  
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Figure 7.2  YaaD intermediate formation  a.  Reaction of YaaD, ribose-5-phosphate 10, 
YaaE and glutamine after 1 minute (solid line) and 5 minutes (dotted line)  b.   
Wavelength scan of the PLP synthase reaction over time:  30 minutes (dotted line); 41 
minutes (dashed line); 56 minutes (dotted line); 71 minutes (dashed line); 105 minutes 
(flat line)  c.  Reaction of YaaD, YaaE, ribose-5-phosphate 10, glutamine and 
dihydroxyacetone phosphate 11.  Intermediate levels reach steady state (squares; 
absorbance 320nm), while product PLP 1 increases (triangles; absorbance 390nm).     77
bound to the enzyme; gel filtration does not separate protein from intermediate 
absorbance at 320nm and all attempts to remove the intermediate from the active site 
have failed.  E. coli ribosephosphate isomerase
3 does not form a similar species when it is 
incubated with ribose-5-phosphate 10 and glutamine or ammonia, indicating this 
intermediate is specific for the PLP synthase reaction.   
 
Ribose-5-phosphate 10 and ribulose-5-phosphate 8 are both substrates for the formation 
of the intermediate, suggesting that isomerization occurs prior to its formation.  The 
formation of the intermediate also depends on YaaD-ribulose-5-phosphate adduct 9  
formation because K149A, the mutant that does not form an adduct with YaaD, is still 
able to isomerize ribose-5-phosphate 10, yet it is unable to form the intermediate.  This 
suggests that the isomerization of ribose-5-phosphate 10 and the adduct 9 formation on 
YaaD are necessary for the intermediate formation.   
 
7.2.3  Intermediate characterization: kinetic isotope effect and PLP synthase 
lag 
After several unsuccessful attempts at isolating the intermediate with an absorbance at 
320nm, we decided to use alternative methods to characterize it.  An absorbance at 
320nm suggests extended conjugation in the putative intermediate; compounds such as 
acrolein and pyridoxine absorb at this wavelength.  To better understand the structure of 
the intermediate, we asked whether we could observe a kinetic deuterium isotope effect 
on the intermediate formation.  Beginning with deuterated ribose, we were able to 
generate the corresponding deuterium-labeled ribose-5-phosphate (labeled separately at 
each carbon C1-C5) in situ using recombinant E. coli ribokinase.
4  We tested each 
compound for a kinetic isotope effect on intermediate formation at 320nm.  To our   78
surprise, we only observed a kinetic isotope effect for the ribose-5-phosphate labeled at 
C5, implying the involvement of one of these two protons in the rate determining step 
towards the intermediate formation.  Table 7.1 summarizes these results.  The observed 
kinetic isotope effect (kH/kD) of 2.1 is large, suggesting that it is a primary kinetic isotope 
effect.  Testing the isotope effect at C1 serves as a nice control since the deuterium at this 
position is non-enzymatically exchanged with the solvent, as observed in the NMR in 
figure 6.3.   
 
Table 7.1  Kinetic deuterium isotope effect on intermediate formation.   
   1-
2H-
ribose-5-
phosphate 
2-
2H- 
ribose-5-
phosphate 
3-
2H- 
ribose-5-
phosphate 
4-
2H- 
ribose-5-
phosphate 
5-
2H- 
ribose-5-
phosphate 
5R-[5-
2H]-
ribose-5-
phosphate 
(6.5:1) 
5S-[5-
2H]-
ribose-5-
phosphate 
(2.5:1) 
kH/kD 1.1±0.1 1.2±0.1 1.1±0.1 1.1±0.03  2.1±0.2  1.8±0.3  1.4±0.2 
kH/kD expected if the C5 pro-R diastereomer causes the isotope effect  1.9  1.3 
kH/kD expected if the C5 pro-S diastereomer causes the isotope effect  1.1  1.7 
 
Further investigation, in collaboration with David Hilmey, revealed that it was the C5 
pro-R enantiomer of ribose-5-phosphate that resulted in the observed isotope effect.   
Dave Hilmey synthesized 5R-[5-
2H]-ribose in a 6.5:1 ratio with 5S-[5-
2H]-ribose and he 
also synthesized the 5S-[5-
2H]-ribose in a 2.5:1 ratio with 5R-[5-
2H]-ribose.  These are 
shown in figure 7.3.  If YaaD abstracts the pro-R proton of ribose-5-phosphate, we would 
expect the 6.5:1 mixture of pro-R: pro-S diastereomers to give a kinetic isotope effect of 
1.9 and the 2.5:1 mixture of pro-S: pro-R would give a kinetic isotope effect of 1.3.  The 
observed isotope effect on the mixture of 6.5:1 pro-R: pro-S was 1.8 and the observed 
isotope effect of the 2.5:1 pro-S: pro-R mixture was 1.4.  These values, which are shown   79
in Table 7.1, are consistent with a kinetic deuterium isotope effect on 5R-[5-
2H]-ribose-5-
phosphate.   
O
OH
HO
OH
HO
H
D
O
OH
HO
OH
HO
D
H
5R-[5-
2H]-ribose 5S-[5-
2H]-ribose
 
 
 
 
Figure 7.3  The pro-R and pro-S diastereomers of ribose synthesized by Dave Hilmey.   
 
Interestingly, although there was no change in the rate of PLP formation with 5-
2H-
ribose-5-phosphate, suggesting that the triose addition is the rate determing step in the 
conversion to PLP 1, we did observe something surprising.  As indicated in figure 6.5, we 
always observe a lag in PLP formation.  When 5-
2H-ribose-5-phosphate was analyzed for 
PLP formation, the lag was exaggerated, as if there was an isotope effect on the lag.  This 
did not happen with the other deuterated substrates, suggesting it was specific for 5-
2H-
ribose-5-phosphate.  An example of this lag is shown in figure 7.4.  The exaggerated lag 
on the PLP synthase reaction observed with 5-
2H-ribose-5-phosphate suggests that it may 
be caused, at least partially, by the slower intermediate formation due to the kinetic 
deuterium isotope effect.  Moreover, we were able to correlate the rate of intermediate 
formation with the rate of the lag, again suggesting that the lag in the PLP synthase 
reaction is partially due to the formation of this intermediate.  The initial rate that we 
observe for PLP formation, therefore, may be the rate of the triose adding to the 
intermediate, and may not include intermediate formation, as this appears to form the lag.   
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Figure 7.4  Lag in PLP synthase reaction with deuterated ribose-5-phosphate.  Dotted line 
is PLP synthase reaction with H-ribose-5-phosphate; line is PLP synthase reaction with 5-
2H-ribose-5-phosphate.  5-
2H-ribose-5-phosphate gave about 2x the lag phase.   
Figure 7.4  Lag in PLP synthase reaction with deuterated ribose-5-phosphate.  Dotted line 
is PLP synthase reaction with H-ribose-5-phosphate; line is PLP synthase reaction with 5-
2H-ribose-5-phosphate.  5-
2H-ribose-5-phosphate gave about 2x the lag phase.   
   
Our results suggest that a transimination between ammonia and the YaaD-adduct 9 
releases the adduct from YaaD to form 13 and that this species is further processed by C5 
deprotonation to form an intermediate that absorbs at 320nm.  To be consistent with the 
experimental results, we suggest that the amino-ribulose-5-phosphate 13 tautomerizes to 
14, followed by water elimination to form 15 and C5 deprotonation to form 16, the 
proposed intermediate.  This is shown in figure 7.5.   
Our results suggest that a transimination between ammonia and the YaaD-adduct 9 
releases the adduct from YaaD to form 13 and that this species is further processed by C5 
deprotonation to form an intermediate that absorbs at 320nm.  To be consistent with the 
experimental results, we suggest that the amino-ribulose-5-phosphate 13 tautomerizes to 
14, followed by water elimination to form 15 and C5 deprotonation to form 16, the 
proposed intermediate.  This is shown in figure 7.5.   
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Figure 7.5  Proposed mechanism of intermediate formation at 320nm.    Figure 7.5  Proposed mechanism of intermediate formation at 320nm.   
   
7.2.4  Triose addition to the intermediate  7.2.4  Triose addition to the intermediate 
We have characterized the first bond formed in the PLP synthase reaction and also 
observe a stable intermediate 16 that forms in the absence of the triose.  To determine 
how the triose adds to the intermediate 16, we looked at which triose, dihydroxyacetone 
phosphate  11 or glyceraldehyde-3-phosphate 12, reacts faster with 16.  If 
We have characterized the first bond formed in the PLP synthase reaction and also 
observe a stable intermediate 16 that forms in the absence of the triose.  To determine 
how the triose adds to the intermediate 16, we looked at which triose, dihydroxyacetone 
phosphate  11 or glyceraldehyde-3-phosphate 12, reacts faster with 16.  If   81
dihydroxyacetone phosphate 11 reacts faster, we would predict C-C bond formation 
between dihydroxyacetone phosphate 11 and the intermediate, as shown in figure 7.6 
reaction A.  The carbonyl at C2 of dihydroxyacetone phosphate 11 is set up for C-C bond 
formation.  Alternatively, if glyceraldehyde-3-phosphate 12 reacts faster with the 
intermediate, we hypothesize that C-N bond formation between the C1 of 
glyceraldehyde-3-phosphate 12 and the intermediate amine group would occur to yield 
21 (figure 7.6 reaction B).  The aldehyde at C1 allows for a facile imine reaction between 
the two species.   
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Figure 7.6  Two possible reactions between the triose and the intermediate.   A shows C-
C bond formation between dihydroxyacetone phosphate 11 and the intermediate and B 
shows C-N bond formation between glyceraldehyde-3-phosphate 12 and the intermediate.   
 
Both dihydroxyacetone phosphate 11 and glyceraldehyde-3-phosphate 12 cause the 
intermediate at 320nm to decay with time, however, the reactions appear different by 
UV-Vis.  When we monitor the formation of the intermediate in the presence of 
dihydroxyacetone phosphate 11, we observe a similar amplitude for intermediate 
formation compared to the reaction without triose.  This is followed by a slow decay to 
approach the steady state level of intermediate.  This is shown in figure 7.7.   
Glyceraldehyde-3-phosphate  12 addition to the intermediate yields something very 
different:  the observed initial rate of intermediate formation appears slow compared to   82
dihydroxyacetone phosphate 11 addition and the reaction approaches the steady state 
level of intermediate without any apparent decrease, also shown in figure 7.7.  The 
difference in amplitude between the dihydroxyacetone phosphate 11 reaction and the 
glyceraldehyde-3-phosphate  12 reaction is not due to the rate of formation of the 
intermediate, which is the same in both cases, it is due to the rate of decay of the 
intermediate.  The rate of intermediate decay is embedded in the rate of intermediate 
formation; the difference in amplitude implies that glyceraldehyde-3-phosphate 12 reacts 
with the intermediate faster than dihydroxyacetone phosphate 11.  At every time point, 
although the intermediate is formed at the same rate, glyceraldehye-3-phosphate 12 reacts 
faster with the intermediate, giving it a lower amplitude compared to dihydroxyacetone 
phosphate 11.  Varying the concentration of triose changes the apparent initial rate and 
the amplitude of the intermediate, verifying that the differences we observe are due to 
triose addition to the intermediate.   
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Figure 7.7  Intermediate formation in the presence of dihydroxyacetone phosphate 11 
(dotted line); glyceraldehyde-3-phosphate 12 (dashed line); and no triose (filled line).   
 
As described above, glyceraldehyde-3-phosphate 12 is able to add to the intermediate 16 
faster than dihydroxyacetone phosphate 11, and we wanted to know whether this was 
because dihydroxyacetone phosphate 11 needs to isomerize before it can react with the 
intermediate.  To test this hypothesis, we formed dihydroxyacetone phosphate deuterated   83
stereospecifically at the C1 position using triose phosphate isomerase in D2O (the 
reaction equilibrium lies in favor of dihydroxyacetone phosphate 22:1
5).  Addition of 1-
2H-dihydroxyacetone phosphate to the intermediate reaction slowed the addition to the 
intermediate compared to the fully protonated substrate, as observed in the different 
amplitudes of intermediate (figure 7.8).  Additionally, triose phosphate isomerase speeds 
up the addition of dihydroxyacetone phosphate 11 to the intermediate when compared to 
dihydroxyacetone phosphate 11 alone.  These results indicate that glyceraldehyde-3-
phosphate 12 reacts faster with the intermediate 16 and dihydroxyacetone phosphate 11 
needs to isomerize prior to reacting with the intermediate.  We suggest that C-N bond 
formation between the C1 of glyceraldehyde-3-phosphate 12 and the intermediate amine 
is the second bond to form in the PLP synthase reaction.  This is shown in figure 7.9.  
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Figure 7.8 Intermediate formation in the presence of dihydroxyacetone phosphate 11 
(dotted line); 1-
2H-dihydroxyacetone phosphate (dashed line); and no triose (filled line).    
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Figure 7.9  C-N bond formation between the C1 of glyceraldehyde-3-phosphate 12 and 
the intermediate amine is consistent with the experimental observations.   
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7.2.5  Phosphate release 
During the course of the PLP synthase reaction, the phosphate from the triose is retained 
and the pentose phosphate is removed.  To determine if the pentose phosphate is 
eliminated or hydrolyzed, we used 500MHz 
31P-NMR and looked for an isotopic shift 
when the PLP synthase reaction was run in 39% 
18O water.  If the phosphate is 
hydrolyzed, as in figure 7.10a, 
18O  would be incorporated into phosphate and we would 
expect 39% of the phosphate signal to be isotopically shifted (note that 0.02ppm can be 
separated at 145MHz
6).  Alternatively, if the phosphate is eliminated, no 
18O would be 
incorporated into the released phosphate and we should observe one signal corresponding 
to all 
16O-phosphate (figure 7.10b).  We did not observe an 
18O-Pi isotopic shift when the 
reaction was run in 
18O water, indicated by the singlet at -46.4ppm (figure 7.11), 
suggesting that the pentose phosphate is eliminated and not hydrolyzed when it is 
released.  Dihydroxyacetone phosphate 11 non-enzymatically eliminates phosphate to 
methyl glyoxal and a fraction of the phosphate peak is due to this.
7   
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Figure 7.10  
31P-NMR experiment summary  a.  If phosphate is hydrolyzed, 39% of the 
phosphate signal will be isotopically shifted by the 
18O-Pi  b.  If phosphate is eliminated, 
no shift will be observed.   
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Figure 7.11  
31P-NMR of the PLP synthase reaction.  No 
18O-Pi isotopic shift is observed, 
indicated by the singlet at -46.4ppm.  DHAP (dihydroxyacetone phosphate), Ru5P 
(ribulose-5-phosphate), Ro5P (ribose-5-phosphate).    
 
7.2.6  PLP synthase reaction in D2O  
When the PLP synthase reaction was run in deuterated buffer, deuterium incorporation 
was observed at the C2’ (2.25ppm) and C6 (7.45ppm) position of PLP (figure 7.12).  
Deuterium incorporation at the C2’ position results from the isomerization of ribose-5-
phosphate 10 and ribulose-5-phosphate 8 and from the non-enzymatic isomerization of 
ribulose-5-phosphate 8, which incorporates deuterium at C1 of the pentulose (refer to 
figure 6.3).  Deuterium incorporation at C6 of the PLP ring was observed when both 
glyceraldehyde-3-phosphate  12 and dihydroxyacetone phosphate 11 w e r e  u s e d  a s  
substrates.  This exchange is most likely due to non-enzymatic isomerization of 
glyceraldehyde-3-phosphate 12 in solution.     
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Figure 7.12  Deuterium incorporation into PLP when the PLP synthase reaction was run 
in deuterated buffer.   
 
7.2.7  2’-hydroxypyridoxol-5’-phosphate is not an intermediate 
It was previously suggested based on labeling studies that 2’-hydroxypyridoxol (or its 
phosphate 17; figure 7.13) is a precursor for vitamin B6 biosynthesis in S. cerevisiae as 
well as in other eukaryotes.
8,9  S. cerevisiae has the YaaD and YaaE family of proteins 
and we wanted to know whether YaaD and YaaE would accept 2’-hydroxypyridoxol as a 
substrate.  When 2’-hydroxypyridoxol or 2’-hydroxypyridoxol-5’-phosphate 17 (in 
collaboration with Brian Lawhorn) were incubated with YaaD and YaaE, or with YaaD 
alone, no PLP 1 or B6 vitamer was observed by HPLC, and the sample did not turn 
yellow.  It is possible that this compound serves as an intermediate in PLP biosynthesis in 
eukaryotes such as yeast (where the labeling studies were done), but the high degree of 
sequence similarity between the eukaryotic YaaD and prokaryotic YaaD suggests that 
this is unlikely.  It is also possible that 2’-hydroxypyridoxol can be metabolized to an 
advanced intermediate (for example, a species such as 2’-hydroxypyridoxol-4’,5’-
phosphate) that is then accepted by PLP synthase.  What is most likely, however, is that 
2’-hydroxypyridoxol is the substrate for a PLP salvage pathway in yeast because it was 
shown to be converted to B6 vitamers in Kloeckera apiculata, a vitamin B6 dependent 
yeast.
9   
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Figure 7.13  2’-hydroxypyridoxol-5’-phosphate, which was tested as a substrate for PLP 
synthase.   
 
7.3  Conclusion 
This chapter provides evidence for the early steps in the PLP synthase reaction, including 
an intermediate that is formed in the absence of the triose substrate.  The first bond 
formed in the PLP synthase reaction is between ammonia and the C2 carbon of ribose-5-
phosphate  10.  Ammonia, produced in the active site of YaaE, travels to YaaD and 
releases the covalent adduct on YaaD to produce 13, shown in figure 7.14.  This species 
is further processed, as indicated by its absorbance at 320nm, by C5 deprotonation to 16.  
Imine formation between the intermediate amine 16 and the C1 of glyceraldehyde-3-
phosphate 12 results in 21.  Two successive tautomerization reactions yield 23.  These 
tautomerization reactions resemble the isomerization of glyceraldehyde-3-phosphate 12 
and dihydroxyacetone phosphate 11 and is probably why YaaD can accept both 
substrates and has triose phosphate isomerase activity.  Water addition to 23 followed by 
phosphate elimination yields 25.  Water elimination, a tautomerization, and another 
elimination of water yields 28.  Finally, tautomerization gives PLP 1.  This mechanism 
does not include 2’-hydroxypyridoxol-5’-phosphate 17, which was shown not to be a 
substrate for PLP synthase.     88
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Figure 7.14  Proposed mechanism of PLP synthase.   
 
7.4  Experimental procedures 
 
7.4.1  Materials and methods 
 
7.4.1.1  Materials:  All chemicals were purchased from Sigma.  Deuterated ribose was 
from Omicron Biochemicals.  ESI-FTMS was performed by the McLafferty group at 
Cornell University.  NMR spectra were obtained on an INOVA 600MHz spectrometer 
and INOVA 500Mhz spectrometer, UV-Vis spectra were obtained on a Hitachi U2010 
spectrophotometer and HPLC was performed on a Hewlett Packard 1100 Series 
instrument.  Microcons were purchased from Amicon, HPLC column was from Supelco 
and desalting columns from BioRad.  Triose phosphate isomerase was from Sigma, 
ribosephosphate isomerase and ribokinase were gifts from the Mowbray lab at Swedish 
University of Agricultural Sciences.  
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7.4.2  Assays 
 
7.4.2.1  Ribose-5-phosphate-ammonia bond formation:   
300μg YaaD was mixed with 120μg YaaE and 13mM glutamine in 50mM tris, pH8 in 
150μL total volume.  A sample with just YaaD and 4mM ribulose-5-phosphate was also 
incubated for 1 hour at 37
oC prior to being frozen at -20
oC for ESI-FTMS analysis.   
 
512μg YaaD and 357μg YaaE were mixed with 2.5mM ribose-5-phosphate in 50mM tris, 
pH8 for 1 hour at room temperature prior to being frozen at -20
oC for ESI-FTMS 
analysis.  Half of the sample was also reduced with NaBH4 and desalted prior to ESI-
FTMS analysis.   
 
70mg YaaD was mixed with 13mM ribulose-5-phosphate and 13mM dihydroxyacetone 
phosphate in 50mM tris, pH8 for 1 hour at 37
oC.  The sample was frozen at -20
oC prior to 
ESI-FTMS analysis.   
 
7.4.2.2  Intermediate formation: 
Absorbance at 320nm:  In general, 150μg YaaD, 150μg YaaE, 2.8mM ribose-5-
phosphate and 2.8mM glutamine were mixed in 50mM tris, pH8 in 350μL total volume.  
Wavelength scans were taken every few minutes on a UV-Vis spectrophotometer.   
 
Full reaction:  In general, 150μg YaaD, 150μg YaaE, 2.8mM ribose-5-phosphate, 
2.8mM dihydroxyacetone phosphate and 2.8mM glutamine were mixed in 50mM tris, 
pH8 in 350μL total volume.  Wavelength scans were taken every few minutes on a UV-
Vis spectrophotometer. 
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Isotope effect:  In general, 2.5mg YaaD, 2.5mg YaaE, 1.8mM dihydroxyacetone 
phosphate and 1.8mM glutamine were incubated at room temperature in a total volume of 
830μL.  After 40 minutes, the samples were desalted into tris.  This releases the excess 
ribose-5-phosphate that purifies out with YaaD.  200μg ribokinase, preincubated with 2 
mM ribose (or the corresponding deuterated ribose), 3mM ATP and 0.53mM MgSO4 in 
25mM phosphate pH8 was added to 150μg YaaDE (with no adduct) and 2.8mM 
glutamine in 350μL total.  Absorbance at 320nm was monitored with time using a UV-
Vis spectrophotometer.   Additional experiments were performed in the presence of 
2.8mM dihydroxyacetone phosphate.   
 
Lag:  To remove the adduct from YaaD, 3mg YaaD, 2mg YaaE, 3.3mM 
dihydroxyacetone phosphate and 3.3mM glutamine were mixed for 45minutes and then 
desalted into biospin columns into tris.  340μg ribokinase was preincubated with 4mM 
ATP, 4mM ribose and 0.3mM MgSO4 for 5minutes at room temperature.  To this, 300μg 
YaaDE, 4mM glutamine and 4mM dihydroxyacetone phosphate were combined in 
25mM phosphate, pH8 in 350μL total volume.  Absorbance at 410nm was monitored 
with time.   
 
7.4.2.3  Triose addition to the intermediate: 
Intermediate decay with trioses:  150μg YaaD, 105μg YaaE, 2mM glutamine, 2mM 
ribose-5-phosphate and 5mM dihydroxyacetone phosphate or 5mM glyceraldehyde-3-
phosphate were combined in 25mM phosphate, pH8, 350μL total volume.  Absorbance at 
320nm was monitored with time.   
 
1-
2H-DHAP vs. H-DHAP:  4units triose phosphate isomerase was mixed with 1mM 
dihydroxyacetone phosphate in either H2O (for H-DHAP) or D2O (for 1-
2H-DHAP) 
phosphate buffer.  After incubating overnight at room temperature, the protein was   91
removed and the sample lyophilized.  150μg YaaD, 104μg YaaE, 4.8mM ribose-5-
phosphate, 4.8mM glutamine were mixed with either 5.7mM 1-
2H-DHAP or H-DHAP in 
25mM phosphate, pH8 in 350μL total volume.  The reaction was monitored at 320nm 
with time.   
 
Triose phosphate isomerase:  150μg YaaD, 102μg YaaE, 2.8mM ribose-5-phosphate, 
2.8mM glutamine and 2.8mM dihydroxyacetone phosphate were mixed with or without 
10units of triose phosphate isomerase in 25mM phosphate, pH8 in 350μL total.  The 
reactions were monitored at 320nm with time.   
 
7.4.2.4  Phosphate release: 
1.5mg YaaD, 1.5mg YaaE, 5.2mM ribose-5-phosphate, 5.2mM dihydroxyacetone 
phosphate and 5.2mM glutamine were mixed in 25mM NaHCO3 buffer in 770μL total, 
with 300μL H2O
18 and 50μL D2O.  After 23 hours at room temperature, the sample was 
analyzed on a 500MHz NMR spectrometer with 2400 scans, as well as a 300MHz 
spectrometer. 
 
7.4.2.5  PLP synthase reaction in D2O:   
In general, 2mg YaaD, 2mg YaaE, 4.3mM ribose-5-phosphate, 4.3mM dihydroxyacetone 
phosphate and 4.3mM glutamine were mixed in phosphate buffer in D2O, pH8.2.  The 
reaction was left at 37
oC for 21 hours, and 3mg alkaline phosphatase and 1mM MgSo4 
were added for another 1.5 hours.  The protein was removed with microcon concentrators 
and the samples were partially lyophilized to reduce the volume.  The sample was 
analyzed by HPLC with a LC-18-T column, 15cm x 4.6mm, 3μm with the following 
solvent system:  A, water; B, 100mM KH2PO4 pH6.6; C, methanol.  0-6minutes, 100% 
B; 7minutes, 10% C; 20minutes, 30% C, 30% A; 22minutes, 100% B.  The peak 
corresponding to pyridoxal was collected, lyophilized, and analyzed with 600MHz NMR.     92
7.4.2.6  2’-hydroxypyridoxol-5’-phosphate is not an intermediate:   
70μg YaaD and 18μg YaaE were mixed with 0.33mM 2’-hydroxypyridoxol-5’-phosphate 
(Brian Lawhorn, Notebook B
10-12) in 25mM tris, pH8, 60μL total.  After 16 hours at 
37
oC, the protein was removed with a microcon and the sample injected into the HPLC 
(LC-18-T column, 15cm x 4.6mm, 3μm with the following solvent system:  A, water; B, 
100mM KH2PO4 pH6.6; C, methanol.  0-6minutes, 100% B; 7minutes, 10% C; 
20minutes, 30% C, 30% A; 22minutes, 100% B).     
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 Chapter 8 
 
 
Substrate Analogs 
 
8.1  Introduction 
In an attempt to understand the mechanism of PLP synthase in more detail, we 
synthesized substrate analogs that could potentially inhibit, or trap, both early and 
advanced intermediates in the transformation to PLP.  These substrate analogs could also 
be used in crystallography trials.   
 
This chapter will discuss the synthesis and analysis of 3-deoxyribose-5-phosphate 29 and 
ribose-5-phosphonate  30 as ribose-5-phosphate 10 analogs, and hydroxyacetone 
phosphate 31 and 2-deoxyglyceraldehyde-3-phosphate 32 as triose 11 and 12 analogs.  
The structures of these analogs are shown in figure 8.1.   
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Figure 8.1  Ribose-5-phosphate 10 analogs and triose 11 and 12 analogs synthesized and 
analyzed for inhibition and mechanistic studies on PLP synthase.   
 
The hydroxyl group on C3 of ribose-5-phosphate 10 stays during the course of the PLP 
synthase reaction and ends up on C3 of PLP 1.  If the C3 hydroxyl is used during the 
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course of the reaction, for example, during a tautomerization, we would expect this step 
to be inhibited with 3-deoxyribose-5-phosphate 29.  We could monitor the inhibition 
using the techniques described in chapters 6 and 7 to answer the following questions:  
does YaaD isomerize the inhibitor; does the inhibitor form an adduct with YaaD; does it 
form the intermediate?  Similar questions could be asked for ribose-5-phosphonate 30, 
which would not be able to eliminate phosphate. 
 
We used hydroxyacetone phosphate 31 and 2-deoxyglyeraldehyde-3-phosphate 32 as 
substrate analogs of the triose.  Only the phosphate of the triose remains during the 
course of the PLP synthase reaction and the hydroxyls at C1 and C2 are eliminated as 
water.  We would use hydroxyacetone phosphate 31 and 2-deoxyglyceraldehyde-3-
phosphate  32 to monitor the decay of the intermediate absorbance at 320nm to trap 
intermediates sensitive to these steps.  These compounds could also provide additional 
support for the order of bond formation.   
 
8.2  Results and discussion 
 
8.2.1  3-Deoxyribose-5-phosphate 29 
In the transformation to PLP, only the hydroxyl group at C3 of ribose-5-phosphate 10 is 
retained.  If we remove this hydroxyl from the starting material, we would expect any 
step involving this hydroxyl, such as a tautomerization, to be inhibited.  Although the 
proposed mechanism outlined in figure 7.14 does not involve any chemistry at the C3 
hydroxyl, we can still use this compound to test for inhibition to ascertain whether the 
proposed mechanism is correct.  For example, if 3-deoxyribose-5-phosphate is 
isomerized by YaaD, forms the intermediate, and does not make PLP, we know that it 
binds and does chemistry, however, a step beyond intermediate formation is inhibited by   96
this compound.  This scenario would require modification of the second part of the 
mechanistic proposal.   
 
3-deoxyribose-5-phosphate was synthesized as outlined in figure 8.2.  Briefly, 
commercially available 1,2-isopropylidene-D-xylose 33 was converted to the protected 
phosphate 34 using chloro dibenzylphosphite, which was generated in situ with dibenzyl 
phosphite and n-chlorosuccinamide.
1  This compound was converted to the 
phenylthionocarbonate 35, which allowed for the deoxygenation of the 3’ hydroxyl via a 
reduction with tin hydride.
2  Deprotection of the isopropyl groups and benzyl groups 
afforded 3-deoxyribose-5-phosphate 29.
1,2  NMR confirmed the formation of the products 
at each step and due to the complexity of the NMR spectrum of the product, ESI-MS 
confirmed the formation of 3-deoxyribose-5-phosphate with a molecular ion at 213 m/z.   
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Figure 8.2  Synthesis of 3-deoxyribose-5-phosphate 29.   
 
To determine whether 3-deoxyribose-5-phosphate 29 is an inhibitor of PLP synthase, 
YaaD was preincubated with various concentrations of 3-deoxyribose-5-phosphate 29 
and the remaining substrates and YaaE were added and analyzed for PLP formation.  
Under these conditions, no inhibition was observed with 3-deoxyribose-5-phosphate 29 
up to 6mM.  To test whether 3-deoxyribose-5-phosphate 29 is a substrate for   97
isomerization by YaaD, we looked for deuterium incorporation into 3-deoxyribose-5-
phosphate 29 by ESI-MS.  No H-D exchange was observed by ESI-MS, suggesting YaaD 
is unable to isomerize 3-deoxyribose-5-phosphate 28, and that the compound is neither an 
inhibitor nor a substrate for YaaD.   
 
8.2.2  Ribose-5-phosphonate 30 
In the transformation to PLP, the phosphate of ribose-5-phosphate 10 is removed, and 
that of the triose is retained.  We would expect an analog of ribose-5-phosphate 10 that is 
unable to have the phosphate removed to be an inhibitor.  We chose to synthesize ribose-
5-phosphonate 30, in which the carbon-oxygen bond between ribose and phosphate is 
replaced by a carbon-carbon bond, making the bond scission impossible.  Based on the 
proposed mechanism outlined in figure 7.14, we would expect ribose-5-phosphonate to 
inhibit the PLP synthase catalyzed phosphate elimination from 24 to 25.  The reaction 
would proceed as in figure 8.3, but it would be unable to continue beyond 24*.  This 
inhibitor could also tell us whether phosphate is present in the intermediate 16 or if it is 
removed prior to intermediate formation. 
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Figure 8.3  Proposed mechanism of inhibition by ribose-5-phosphonate 30.  * are the 
phosphonate derivatives of the proposed reaction intermediates.   
 
As outlined in figure 8.4, the secondary hydroxyls of ribose 38 were protected in acid 
using methanol and acetone.
3  After protection, the primary hydroxyl at C5 was oxidized 
using Mofatt conditions, and a Horner-Emmons condensation using the 
tetraethylmethylene diphosphonate carbanion afforded the protected phosphonate 41.
4,5    98
Hydrogenation followed by two subsequent deprotections yielded the free phosphonate 
30.
5,6  NMR confirmed the formation of the products at each step and due to the 
complexity of the NMR spectrum of the product, ESI-MS confirmed the formation of 
ribose-5-phosphonate 30 with a molecular ion at 227 m/z.  
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Figure 8.4  Synthesis of ribose-5-phosphonate 30.   
 
To determine whether ribose-5-phosphonate 30 is an inhibitor of PLP synthase, YaaD 
was preincubated with various concentrations of ribose-5-phosphonate 30 and the 
remaining substrates and YaaE were added and analyzed for PLP formation.  Under these 
conditions, no inhibition was observed with ribose-5-phosphonate 30 up to 6mM.  To test 
whether ribose-5-phosphonate 30 is a substrate for isomerization by YaaD, we looked for 
deuterium incorporation into ribose-5-phosphonate 30 by ESI-MS.  No H-D exchange 
was observed by ESI-MS, suggesting YaaD is unable to isomerize ribose-5-phosphonate 
30, and that the compound is neither an inhibitor nor a substrate for YaaD.   
 
8.2.3  Hydroxyacetone phosphate 31 
Chapter 7 describes the formation of an intermediate absorbance at 320nm during the 
course of the PLP synthase reaction in the absence of triose.  We propose 
glyceraldehyde-3-phosphate then adds to this intermediate 16.  To provide further   99
evidence of this, we synthesized hydroxyacetone phosphate and tested it for addition to 
the intermediate 16.    Hydroxyacetone phosphate is missing the hydroxyl at C1 and 
retains the ketone at C2.  If the C2 carbonyl of dihydroxyacetone phosphate 11 reacts first 
with the intermediate, as shown in figure 7.6 reaction A, we would expect to see a decay 
in the intermediate upon the addition of hydroxyacetone phosphate 31.  This is shown in 
figure 8.5.  Hydroxyacetone phosphate 31 was synthesized in two steps and tested for 
addition to the intermediate.   
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Figure 8.5  Proposed reaction between the intermediate 16 and the putative inhibitor 
hydroxyacetone phosphate 31  if C-C bond formation between the triose and the 
intermediate 16 occurs first.   
 
To synthesize hydroxyacetone phosphate 31, acetol 44 was converted to the protected 
phosphite 45 with diisopropyldibenzylphosphoramidite (DDP) and tetrazole.  Following 
oxidation to the phosphate with 3-chloroperoxybenzoic acid (mCPBA), hydroxyacetone 
phosphate 31 was formed upon hydrogenation (figure 8.6).   
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Figure 8.6  Synthesis of hydroxyacetone phosphate 31.   
 
To test whether hydroxyacetone phosphate 31 could react with the characterized 
intermediate 16 on YaaD/YaaE, the intermediate was pre-formed on YaaD/YaaE and the   100
small molecules were removed by desalting.  Addition of up to 8.6mM hydroxyacetone 
phosphate 31 had no affect on the decay of the intermediate, indicating that it does not 
react with the intermediate.  This suggests that either hydroxyacetone phosphate 31 
cannot react because it does not have the hydroxyl group at C1 (as we would predict), or 
that it is not binding PLP synthase.  Up to 5.7mM hydroxyacetone phosphate 31 did not 
interfere with PLP formation when assayed in the presence of 0.2mM dihydroxyacetone 
phosphate 11, indicating that it is not an inhibitor of PLP synthase and it is probably not 
binding at all.   
 
8.2.4  2-Deoxyglyceraldehyde-3-phosphate 32 
Since hydroxyacetone phosphate 31 retained the C2 carbonyl and did not react with the 
intermediate, we thought that 2-deoxyglyceraldehyde-3-phosphate 32, which retains the 
aldehyde at the C1 position of the triose, would react with the intermediate as 
glyceraldehyde-3-phosphate 12 does in figure 7.6 reaction B.  Because it is missing the 
C2 hydroxyl, we propose that this putative inhibitor would react with the intermediate 16 
and inhibit the tautomerization step proposed from 22 to 23 in figure 7.14.  The proposed 
mechanism of inhibition is shown in figure 8.7.   
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Figure 8.7  Proposed mechanism of inhibition with 2-deoxyglyceraldehyde-3-phosphate 
32.  * are the derivatives of the proposed reaction intermediates. 
 
To synthesize 2-deoxyglyceraldehyde-3-phosphate 32,
7 trans-cinnamaldehyde 46 was 
converted to the epoxide 47 with trimethylsulfonium iodide (TMSI) in sodium hydride 
and DMSO (figure 8.8).  Diisobutylaluminum hydride (DIBAL-H) converts the epoxide   101
to the alcohol 48.  A protected phosphite was added with 
diisopropyldibenzylphosphoramidite (DDP) and tetrazole.  Following oxidation to the 
phosphate  49, the compound was subject to ozonolysis to afford the aldehyde 50.  
Hydrogenation over Pd/C deprotected the phosphates, resulting in 2-
deoxyglyceraldehyde-3-phosphate 32.  The final two steps in this synthesis, ozonolysis 
and hydrogenation, were done in collaboration with David Hilmey.     
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Figure 8.8  Synthesis of 2-deoxyglyceraldehyde-3-phosphate 32. 
 
When 5.7mM 2-deoxyglyceraldehyde-3-phosphate 32 was added to the pre-formed 
intermediate, there was no change in the absorbance spectrum; it had no affect on 
intermediate decay.  This suggests that 2-deoxyglyceraldehyde-3-phosphate does not 
react with the intermediate in PLP synthase.   
 
8.3  Conclusion 
Neither of the modified pentoses, 3-deoxyribose-5-phosphate 29 nor ribose-5-
phosphonate 30, were substrates or inhibitors for PLP synthase.  Likewise, neither of the 
triose analogs, hydroxyacetone phosphate 31 nor 2-deoxyglyceraldehyde-3-phosphate 32, 
reacted with the proposed intermediate 16 in the PLP synthase reaction.  These results 
suggest that the active site of YaaD is probably very specific.     102
8.4  Experimental procedures  
 
8.4.1  Materials and methods:  All chemicals were purchased from Sigma.  ESI-MS 
was performed at Cornell University’s Bioresource Center.  NMR spectra were obtained 
on a Mercury 300MHz spectrometer, UV-Vis spectra were obtained on a Hitachi U2010 
spectrophotometer.   
 
8.4.1.1  Synthesis of 3-deoxyribose-5-phosphate 29 
1,2-isopropylidene-D-xylose-5-dibenzylphosphate 34:  15.6mmol dibenzylphosphite and 
15.6mmol n-chlorosuccinamide were mixed in 20mL dry benzene for 2 hours at room 
temperature.  The mixture was dry filtered to remove undissolved n-chlorosuccinamide, 
and the filtrate was added dropwise to 5.2mmoles of 1,2-isopropylidene-D-xylose 33 in 
20mL pyridine at -40
oC.  After 15 minutes at -40
oC, the reaction was stirred at room 
temperature for 2 hours.  The solvent was evaporated, and 200mL ethyl acetate was 
added.  The mixture was extracted with 2x60mL 1M HCl, 2x60mL 1M NaHCO3, and 
60mL brine.  After the mixture was dried with MgSO4 and filtered, the product was 
purified by flash chromatography with 98:2 chloroform: methanol.  NMR CDCl3 (ppm):  
7.35s 10H; 5.0m 4H; 4.25t 2H; 4.05q 1H; 4.25d 1H; 4.55d 1H; 5.9d 1H; 1.31s 3H; 1.48s 
3H. 
 
1,2-isopropylidene-3-phenylthonocarbonate-D-xylose-5-dibenzylphosphate  35:  
3.9mmole 1,2-isopropylidene-D-xylose-5-dibenzylphosphate  34  was added to 15mL 
dichloromethane and 0.85mmoles dimethylaminopyridine.  The mixture was placed on 
ice and after 4.5mmoles of pyridine was added, 2.5mmoles PHOC(S)Cl in 1.36mL 
dichloromethane was added dropwise.  The reaction was kept on ice for 15 minutes and 
then left at room temperature overnight.  The reaction was extracted with 3x10mL water, 
2x7mL saturated CuSO4 and 10mL brine.  After the mixture was dried with MgSO4 and   103
filtered, the product was purified by flash chromatography with 99.5:0.5 chloroform: 
methanol.  NMR CDCl3 (ppm):  7.35s 10H; 5.1dd 4H; 4.3t 2H; 4.55td 1H; 5.65d 1H; 4.3t 
1H; 6.0d 1H; 1.35s 3H; 1.55s 3H.   
 
1,2-isopropylidene-3-deoxy-D-ribose-5-dibenzylphosphate  36:  1.13mmoles 1,2-
isopropylidene-3-phenylthonocarbonate-D-xylose-5-dibenzylphosphate 35 was added to 
6mg AIBN in 10mL toluene.  The reaction was kept under argon for 30 minutes at room 
temperature.  1.3mmoles tributyltin hydride was added and the reaction was refluxed at 
100
oC  for 3 hours.  The reaction was cooled, solvent evaporated, and purified by flash 
chromatography with 3:1 hexane:ethyl acetate.  NMR CDCl3 (ppm): 7.35s 10H; 5.05dd 
4H; 4.15ddd 1H; 4.0ddd 1H; 4.35m 1H; 2.0dd 1H; 1.7ddd 1H; 4.65t 1H; 5.77d 1H; 1.31s 
3H; 1.48s 3H. 
 
3-deoxy-D-ribose-5-dibenzylphosphate 37:  0.90mmoles 1,2-isopropylidene-3-deoxy-D-
ribose-5-dibenzylphosphate  36 was added to 15mL THF and 960μL 2N HCl.  The 
sample was refluxed at 65
oC for 3 hours.  The reaction was cooled to room temperature 
and bicarbonate was added to neutralize.  The sample was extracted with 10mL ether.  
Extraction continued with 10mL water and 10mL NaCl.  Flash chromatography in 95:5 
chloroform:methanol afforded the product.  NMR CDCl3 (ppm):  α, β-anomers, 7.35m 
20H; 5.05m 8H; 3.9ddd 2H; 4.05ddd 2H; 4.4m 1H; 4.5m 1H; 1.95ddd 2H; 2.05ddd 2H; 
4.2m 1H; 4.26m 1H; 5.25s 1H; 5.28d 1H.   
 
3-deoxy-D-ribose  29:  0.10mmoles 3-deoxy-D-ribose-5-dibenzylphosphate  37  was 
hydrogenated in 20mL THF and 10mg Pd/C.  After 4 hours, the reaction was filtered, 
washed with water, evaporated and lyophilized.  MS (m/z):  213.   
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8.4.1.2  Synthesis of ribose-5-phosphonate 30 
Methyl-2,3-O-isopropylidene-β-D-ribofuranoside 39:  16mmoles ribose 38 was added to 
11mL acetone, 11mL methanol and 0.33mL HCl.  The reaction was refluxed for 2 hours 
and then cooled to room temperature.  30mL water was added and the mixture was 
extracted with 4x30mL chloroform.  The organic layer was dried with MgSO4, filtered 
and evaporated.  NMR CDCl3 (ppm):  3.55m 2H; 4.48d 1H; 4.7d 1H; 4.87s 1H; 3.3s 3H; 
1.2s 3H; 1.37s 3H.   
 
Methyl-2,3-O-isopropylidene-5-dehydro-β-D-ribofuranoside  40:  8mmoles  methyl-2,3-
O-isopropylidene-β-D-ribofuranoside 39 was added to 14mmoles pyridine, 14mmoles o-
phosphoric acid and 45mmoles DCC in 20mL DMSO.  After 7 hours at room 
temperature, the reaction was poured into 0.111moles oxalic acid in 30mL methanol on 
ice and stirred for 45 minutes.  10mL ether was added and the salts were filtered.  The 
sample was evaporated and water added.  The mixture was extracted with 300mL ether, 
evaporated and left on the high vacuum line overnight.   
 
Methyl-2,3-O-isopropylidene-5-deoxy-5-diethylphosphomethylene-β-D-ribofuranoside 
41:  8mmoles sodium hydride was added to 6mmoles tetraethylmethylene diphosphonate 
in 5mL dry THF over ice.  The reaction was stirred for 2 hours, and then added dropwise 
to 4mmoles methyl-2,3-O-isopropylidene-5-dehydro-β-D-ribofuranoside 40 in 5mL dry 
THF.  After 3 hours at room temperature, the reaction was extracted with ether and water, 
the ether layer was dried with MgSO4, filtered and evaporated.  The product was purified 
by flash chromatography with 1:1 hexane:ethyl acetate.  NMR CDCl3 (ppm):  1.3t 6H; 
4.05m 4H; 5.9ddd 1H; 6.7ddd 1H; 4.75m 1H; 4.65d 1H; 4.6d 1H; 5.0s 1H; 3.35s 3H; 1.3s 
3H; 1.45s 3H.   
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Methyl-2,3-O-isopropylidene-5-deoxy-5-diethylphosphonomethyl-β-D-ribofuranoside 42:  
0.87mmoles methyl-2,3-O-isopropylidene-5-deoxy-5-diethylphosphomethylene-β-D-
ribofuranoside 41 was hydrogenated in 30mL absolute ethanol with 20mg PtO2.  After 
10.5hours, the reaction was filtered and evaporated.  NMR CDCl3 (ppm):  1.2t 6H; 4.0q 
4H; 1.75m 2H; 1.75m 2H; 4.0m 1H; 4.41d 1H; 4.5d 1H; 4.85s 1H; 3.23s 3H; 1.23s 3H; 
1.37s 3H.   
 
Methyl-2,3-O-isopropylidene-5-deoxy-5-phosphonomethyl-β-D-ribofuranoside  43:  
5.7mmoles TMSBr was added to 0.38mmoles methyl-2,3-O-isopropylidene-5-deoxy-5-
diethylphosphonomethyl-β-D-ribofuranoside 42 in 5mL dichloromethane.  After 2 hours 
at room temperature, the solvent was evaporated and 5mL 1:1:1 NH4OH: H2O: MeOH 
was added and stirred for 2 hours.  The reaction was extracted with chloroform and the 
aqueous layer was evaporated prior to lyophilization.  NMR CDCl3 (ppm):  1.6m 2H; 
1.6m 2H; 4.1t 1H; 4.65d 1H; 4.7d 1H; 4.93s 1H; 3.3s 1H; 1.24s 3H; 1.36s 3H.   
 
5-deoxy-5-phosphonomethyl-β-D-ribofuranoside  30:  0.24mmoles methyl-2,3-O-
isopropylidene-5-deoxy-5-phosphonomethyl-β-D-ribofuranoside  41  was dissolved in 
5mL water and the sample was purged with argon.  The mixture was refluxed with 
Dowex 5x4-400 (H
+) for 3 hours under argon.  The resin was filtered and washed, and the 
filtrate was adjusted to pH7 with NaOH.  The sample was lyophilized.  MS (m/z):  227.     
 
8.4.1.3  Synthesis of hydroxyacetone phosphate 31 
hydroxyacetone dibenzylphosphate 45:  0.69mmoles acetol 44 was added to 4mL THF, 
1.4mmoles tetrazole and 0.9mmoles dibenzyl diisopropylphosphoramidite and the 
reaction was stirred at room temperature for 30minutes.  After 30minutes, the phosphate 
was oxidized with 2.4mmoles 3-chloroperoxybenzoic acid in 5mL dichloromethane at -
60
oC, and then allowed to warm to room temperature for 15minutes.  The reaction was   106
neutralized with 5mL 10% NaHSO3 for 10minutes at room temperature, followed by 
extraction into 20mL ether.  The sample was washed with 2x7mL 10% NaHSO3 followed 
by 2x7mL 5% NaHCO3.  Hydroxyacetone dibenzylphosphate was purified by flash 
chromatography with 99:1 chloroform:methanol.  NMR CDCl3 (ppm):  7.35s 10H; 5.1dd 
4H; 4.42d 2H; 2.1s 3H. 
 
hydroxyacetone phosphate 31:  0.17mmoles hydroxyacetone dibenzylphosphate 45 in 
12mL absolute ethanol and 10mg 10% Pd/C was hydrogenated for 30minutes.  The 
reaction was filtered through celite, washed, and the ethanol was evaporated.  The sample 
was resuspended in water, neutralized with NaOH, and lyophilized.  NMR D2O (ppm):  
4.3d 2H; 2.1s 3H.   
 
8.4.1.4  Synthesis of 2-deoxyglyceraldehyde-3-phosphate 32 
1,2-epoxy-4-phenylbut-3-ene 47:  3mL dry THF and 3mL dry DMSO were added to 
6mmoles NaH.  The reaction was cooled in an ice-salt bath.  5.8mmoles TMSI in 4.2mL 
DMSO was added over 5 minutes.  To this, 1.9mmoles trans-cinnamaldehyde 46 was 
added and stirred for 30minutes at 0
oC, then at room temperature for 1 hour.  12.5mL 
cold water was added to the sample slowly, followed by extraction with 3x13mL 
dichloromethane.  The organic layer was dried, filtered and concentrated in vacuo.   
Vacuum distillation afforded the epoxide.  NMR CDCl3 (ppm):  7.3m 5H; 6.8d 1H; 5.9dd 
1H; 3.5m 1H; 3.05t 1H; 2.75m 1H.   
 
4-phenylbut-3-en-1-ol 48:  4.2mmoles DIBAL-H in 1M dichloromethane was added over 
5 minutes to 2.7mmoles of 1,2-epoxy-4-phenylbut-3-ene 47 in 11.5mL dichloromethane 
at -78
oC.  After 3 hours at room temperature, the reaction was again cooled to -78
oC and 
2mL methanol was added dropwise.  After 5 minutes, the reaction was brought to room 
temperature and formed a gel.  The gel was washed with 3x20mL ethyl acetate,   107
concentrated in vacuo and purified by flash chromatography with 80:20 hexane: ethyl 
acetate.  NMR CDCl3 (ppm):  7.3m H; 6.5d 1H; 6.2dt 1H; 3.75t 2H; 2.5q 2H; 2.05s 1H.   
 
4-phenylbut-3-en-1-yl dibenzyl phosphate 49:  0.37mmoles DDP was added to 
0.29mmoles 4-phenylbut-3-en-1-ol 48 and 0.57mmoles tetrazole in 1.6mL THF.  After 
30 minutes at room temperature, the reaction was taken to -60
oC and 0.86mmoles 3-
chloroperoxybenzoic acid in 2mL dichloromethane was added.  After 15 minutes at room 
temperature, 2mL 10% NaHSO3 was added for 10 minutes at room temperature.  8mL 
ether was added and washed with 2x3mL 10% NaHSO3 followed by 2x3mL 5% 
NaHCO3.  The ether layer was dried, filtered and concentrated.  The phosphate was 
purified by flash chromatography with 15:1 dichloromethane: acetone.  NMR CDCl3 
(ppm):  7.35m 15H; 6.45d 1H; 6.15dt 1H; 5.05m 4H; 4.1m 2H; 2.5m 2H.   
 
3-oxopropyl dibenzyl phosphate 50:  (Dave Hilmey) 5mL dichloromethane and 5mL 
methanol were added to 0.7mmoles 4-phenylbut-3-en-1-yl dibenzyl phosphate 49.  Ozone 
was passed through the solution at -78
oC until a blue color persisted (about 30 minutes).  
The reaction was purged with argon and 0.25mL dimethylsulfide was added overnight.  
The solvent was concentrated and flash chromatography with 4:1 ethyl acetate: light 
petroleum yielded the aldehyde.  NMR CDCl3 (ppm):  9.2s 1H; 7.35s 10H; 5.0m 4H; 
4.3m 2H; 2.7m 2H.   
 
2-deoxyglyceraldehyde-3-phosphate 32:  (Dave Hilmey) Hydrogen was passed through a 
solution of 3-oxopropyl dibenzyl phosphate 50 in THF and 10% Pd/C for 30 minutes.  
The solution was filtered through celite, concentrated and water was added.  The pH was 
adjusted to 7 with NaOH and ethanol was added.  The sample was filtered and the filtrate 
saved as 2-deoxyglyceraldehyde-3-phosphate.  NMR D2O(ppm) (hydrate):  5.2t 1H; 
3.78m 2H; 1.85m 2H.     108
8.4.2  Assays 
 
8.4.2.1  3-deoxyribose-5-phosphate 29 inhibition studies 
PLP synthase inhibition:  120μg YaaD was preincubated with various concentrations of 
3-deoxyribose-5-phosphate (120μM – 6mM; 2Km – 100Km) at room temperature.  After 
20 minutes, 120μg YaaE, 60μM ribose-5-phosphate, 2mM dihydroxyacetone phosphate 
and 2mM glutamine were added in 50mM phosphate pH8 to a final volume of 350μL.  
The absorbance at 390nm was monitored with time.  
 
H-D exchange of 3-deoxyribose-5-phosphate by YaaD:  562.5μg YaaD was incubated 
with 5mM 3-deoxyribose-5-phosphate in 2.5mM ammonium bicarbonate in D2O in a 
total volume of 1mL.  The sample was incubated for 15 hours at room temperature, the 
protein was removed with microcon concentrators, and the sample was lyophilized.  The 
samples were resuspended in water and analyzed by ESI-MS.   
 
8.4.2.2  ribose-5-phosphonate 30 inhibition studies 
PLP synthase inhibition:  120μg YaaD was preincubated with various concentrations of 
ribose-5-phosphonate (120μM – 6mM; 2Km – 100Km) at room temperature.  After 20 
minutes, 120μg YaaE, 60μM ribose-5-phosphate, 2mM dihydroxyacetone phosphate and 
2mM glutamine were added in 50mM phosphate pH8 to a final volume of 350μL.  The 
absorbance at 390nm was monitored with time.  
 
H-D exchange of ribose-5-phosphonate by YaaD:  562.5μg YaaD was incubated with 
2.5mM ribose-5-phosphonate in 2.5mM ammonium bicarbonate in D2O in a total volume 
of 1mL.  The sample was incubated for 15 hours at room temperature, the protein was 
removed with microcon concentrators, and the sample was lyophilized.  The samples 
were resuspended in water and analyzed by ESI-MS.   109
8.4.2.3  hydroxyacetone phosphate 31  studies 
hydroxyacetone phosphate reaction with intermediate:  2mg YaaD, 1.4mg YaaE, 3.2mM 
ribose-5-phosphate and 3.2mM glutamine were mixed in 475μL total volume for 30 
minutes in 25mM phosphate pH8.  After the intermediate formed, the solution was 
desalted into phosphate.  335μg YaaDE-intermediate was incubated with 4.8mM 
hydroxyacetone phosphate in 25mM phosphate, pH8.  Absorbance spectra were taken 
over time and the decay at 320nm was monitored over time.   
 
8.4.2.4  2-deoxyglyceraldehyde-3-phosphate 32 studies 
2-deoxyglyceraldehyde-3-phosphate reaction with intermediate:  2mg YaaD, 2mg YaaE, 
3.4mM ribose-5-phosphate and 3.4mM glutamine were mixed in 450μL total volume for 
30 minutes in 25mM phosphate pH8.  After the intermediate formed, the solution was 
desalted into phosphate.  200μg YaaDE-intermediate was incubated with 5.7mM 2-
deoxyglyceraldehyde-3-phosphate in 25mM phosphate, pH8.  Absorbance spectra were 
taken over time.   
 
 
 
 
 
 
 
 
 
 
 
   110
8.5  References 
 
1.  Strauss, E.; Begley, T. (2002) J. Biol. Chem. 277, 48205-48209. 
 
2.  Rizzo, C.; Dougherty, J.; Breslow, R. (1992) Tet. Lett. 33, 4129-4132. 
 
3.  Lerner, L. (1977) Carb. Res. 53, 177-185. 
 
4.  Le Marechal, P.; Froussious, C.; Level, M.; Azerad, R. (1981) Carb. Res. 94, 1-
10. 
 
5.  Burgos, E.; Salmon, L. (2004) Tet. Lett. 45, 3465-3469. 
 
6.  Unger, F. M. S., D.; Moderndorfer, E.; Hammerschmid, F. (1978) Carb. Res. 67, 
349-356. 
 
7.  Cotterill, I.; Shelton, M.; Machemer, D.; Henderson, D.; Toone, E. (1998) J. 
Chem. Soc., Perkin Trans. 1, 1335-1341. 
 
 Chapter 9 
 
 
Conclusion and Outlook 
 
9.1  An Overview 
Compared to the E. coli system, PLP biosynthesis in B. subtilis and other organisms with 
the YaaD/YaaE family of genes is simplified.  What takes six enzymes to do in the E. 
coli system takes only two in the YaaD/YaaE system.  Why some organisms evolved the 
more complex route while others use only two enzymes is not currently known.   
Although the YaaD/YaaE system is simple and efficient in that the enzymes can perform 
the task of six enzymes in two, the reaction catalyzed by the YaaD/YaaE system appears 
to be more complex.  We have shown that YaaD has both ribosephosphate isomerase 
activity as well as triosephosphate isomerase activity, reactions normally catalyzed by 
two separate and essential enzymes in the cell.  YaaD also forms a covalent adduct with 
the product of ribose-5-phosphate isomerization, ribulose-5-phosphate.  YaaD then 
combines ammonia, which is delivered from the amidotransferase subunit YaaE, as well 
as the triose to form the product PLP 1.  Unlike the E. coli system, no further oxidation is 
needed to form the active cofactor.   
 
We have reconstituted the biosynthesis of PLP 1 using YaaD and YaaE from B. subtilis, 
outlined and provided evidence for the order of bond formation, and characterized an 
intermediate formed in the absence of triose.  Unfortunately, all attempts at isolating the 
intermediate with absorbance at 320nm failed.  In addition, all attempts at trapping an 
early or advanced intermediate with substrate analogs also failed.  This may be due, at 
least in part, to the complex structure of the PLP synthase complex.  The structure of the 
YaaD subunit of PLP synthase from Geobacillus stearothermophilus at 2.2Å was solved 
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shortly after the reconstitution.
1  The structure is composed of twelve monomers with a 
classic (β/α)8 barrel fold.  Biochemical evidence supports that the subunit exists as a 
dodecamer and a hexamer in solution.  Recently, in collaboration with the Ealick group, 
we were able to get a crystal structure of the YaaD/YaaE complex from Thermatoga 
maratima at 2.9Å resolution (unpublished).  The PLP synthase complex from T. 
maratima has 12 core YaaD monomers with 12 YaaE monomers surrounding them.  The 
structure is shown in figure 9.1.  The structure has ribulose-5-phosphate bound in the 
active site of YaaD.  The impressive structure of YaaD and the YaaD/YaaE complex 
enabled us to rationalize some of our findings.  For example, because the complex is so 
big, it must take coordination and cooperativity to get the complex ready for catalysis.  
This could explain, at least in part, why the system is very slow, and why it is difficult to 
denature.  The structure also identified key active site residues which were important for 
catalysis.   
Figure 9.1  Structure of the PLP synthase dodecamer  a. View down the molecular sixfold 
axis  b.  View perpendicular to the sixfold axis.  Yellow and red are the YaaD subunits in 
the two hexameric layers that join face-to-face to form the dodecamer.  Green and orange 
are the YaaE monomers surrounding the YaaD core.   
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9.2  Future Directions 
As mentioned above, the crystal structure provided us with some insight into the active 
site residues involved in catalysis.  While a few of these residues were mutated, none of 
them provided any critical information regarding the mechanism (this data was not 
discussed).    The crystal structure did bring up some interesting questions.  Our mass 
spectrometry data suggests the adduct on YaaD is on lysine 149.  The structure of the 
YaaD/YaaE complex, however, has the adduct on lysine 81.  In addition, lysine 149 is 
pointed away from the active site in both the YaaD structure and the structure of the 
YaaD/YaaE complex.  Mutagenesis of either residue abolishes PLP synthase activity.  
The possibility of both residues involved in PLP formation has not been ruled out and a 
more detailed analysis of this apparent discrepancy is needed.  Another question 
regarding the PLP synthase structure is the site of triose isomerization.  Neither structure 
has the triose bound, and neither has an obvious binding pocket for the triose.  Future 
studies will focus on determining which residues are important for catalyzing triose 
isomerization, as this could enable us to trap advanced intermediates with substrate 
analogs.   
 
The PLP synthase reaction is complex, slow, and most likely has many steps in the 
mechanism.  Because there are quite a few optical signals (ribulose-5-phosphate absorbs 
at 290nm; intermediate absorbance at 320nm; PLP absorbance at 390nm), and the 
mechanism appears to involve ordered bond formation, the PLP synthase reaction can be 
monitored step-wise by absorbance changes.  This will enable us to get rates for 
formation and decay of the optical signals so we can get a kinetic picture of the 
mechanism.  The PLP synthase reaction is far too complicated to understand without 
putting rates on the signals we observe. 
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Interestingly, in S. cerevisiae and other fungi, vitamin B6 forms the backbone of the 
cofactor thiamin.
2  S. cerevisiae contains three sets of PLP synthase genes, and one set of 
these genes clusters with thiamin biosynthetic genes.  Unpublished results from our lab 
suggest that the product of the PLP synthase genes in S. cerevisiae is PLP, however, the 
system is unable to isomerize ribose-5-phosphate to ribulose-5-phosphate (Jennie 
Sanders).  Additional evidence suggests that these enzymes require ribosephosphate 
isomerase for in vivo activity, 
3 so the 5-carbon substrate in S. cerevisiae is most likely 
ribulose-5-phosphate.  The activity of the PLP synthase enzymes from S. cerevisiae is 
robust compared to the activity of the enzymes from B. subtilis, and it may provide a 
better system for studying the mechanism of PLP formation by this family of enzymes.  
Moreover, it will enable us to probe thiamin biosynthesis in yeast in more detail.   
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